Speech therapy

Z21_SPEECH_THERAPY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — Z50.1 Hospital discharge: ICD-10 — Z50.1 Cause of death: ICD-10 — Z50.1 3 out of 7 registries used, show all original rules.	12356
4. Check minimum number of events None	12356
5. Include endpoints None	12356
6. Filter based on genotype QC (FinnGen only)	11962

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF9

NAME	Z21_SPEECH_THERAPY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	Z501
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Z501
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Z501
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Speech therapy based on the number of shared cases.

Similar with more cases:

Any event in hilmo or specialist outpatient

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	11962	7306	4656
Unadjusted period prevalence (%)	2.41	2.59	2.13
Median age at first event (years)	59.62	57.60	62.78

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12356: Matched controls
123560

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.3

313.2

2912

14395

A97

ICPC

No disease

2.4

308.9

2778

13527

Z71.9

ICD-10 Finland

Counselling, unspecified

6.6

307.7

2261

4062

R4110

NOMESCO Finland

Physiotherapy

5.1

307.7

6598

22820

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

4.7

307.7

1026

2346

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

24.0

307.7

586

256

Z25.1

ICD-10 Finland

Need for immunization against influenza

3.8

307.7

1130

3225

Z01.3

ICD-10 Finland

Examination of blood pressure

17.2

307.7

677

414

Z51.88

ICD-10 Finland

Other specified medical care

11.8

307.7

896

814

N03AX16

ATC

[U] pregabalin

2.3

307.7

3705

19583

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

307.7

5223

31984

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

9.1

307.7

1371

1674

Z3226

NOMESCO Finland

Physiotherapist

4.1

307.7

4245

13888

WZC30, ,

SPAT

4.7

307.7

1360

3185

Z12.3

ICD-10 Finland

Special screening examination for neoplasm of breast

21.0

307.7

410

202

Z50.1

ICD-10 Finland

Other physical therapy

+∞

307.7

12356

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.8

307.7

1876

4435

ZXD10

NOMESCO Finland

Scheduled procedure

2.5

307.7

6089

34231

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

3.9

307.7

1134

3138

R4120

NOMESCO Finland

Occupational therapy

3.5

307.7

1286

4000

Z3231

NOMESCO Finland

Registered nurse

3.1

307.7

5038

22718

Z01.7

ICD-10 Finland

Laboratory examination

3.0

307.7

2708

10455

XFE00

NOMESCO Finland

Epicardial ultrasonography

6.2

307.7

627

1048

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.4

307.7

1530

4985

Z26.9

ICD-10 Finland

Need for immunization against unspecified infectious disease

17.0

307.7

780

488

FP1E5, ,

SPAT

54.2

307.7

187

XA402

NOMESCO Finland

ENMG

6.2

307.7

716

1205

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

4.1

307.7

1926

5355

ZXA00

NOMESCO Finland

Right side

2.4

307.7

4327

22662

ZXA05

NOMESCO Finland

Left side

2.4

307.7

4089

20823

SPAT1236

SPAT

Informing family of child’s disability

20.4

307.7

1304

710

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

53.8

307.7

1216

250

A29

ICPC

General symptom/complaint other

2.8

307.7

2280

9167

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

3.3

307.7

2152

7465

R1250

NOMESCO Finland

Evaluation of functional capability

6.3

307.7

611

1016

X59

ICD-10 Finland

Exposure to unspecified factor

2.5

307.7

3062

14357

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

3.4

307.7

3685

13854

L29

ICPC

Musculoskeletal sympt/complt other

3.0

307.0

1572

5808

U28

ICPC

Limited function/disability (U)

9.5

291.7

348

375

-60

ICPC

Result test/procedure

3.4

291.4

1123

3503

Z2221

NOMESCO Finland

Medical doctor

2.1

281.4

3937

22744

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

278.3

3778

21567

Z3229

NOMESCO Finland

Other healthcare associate professional

2.9

274.5

1484

5630

R4135

NOMESCO Finland

Rehabilitation for hearing problems

6.2

272.4

479

804

B01AB05

ATC

enoxaparin; parenteral

2.0

271.6

4564

28076

-62

ICPC

Administrative procedure

4.6

250.1

617

1398

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

248.4

3178

17624

-69

ICPC

Other reason for encounter NEC

3.8

243.9

772

2107

N02AX02

ATC

tramadol; systemic, rectal

1.9

237.9

5801

39842

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.2

237.2

989

3227

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.1

232.8

1060

3642

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

231.2

2170

10624

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.3

229.9

941

3035

ZXE00

NOMESCO Finland

One hour or less

1.8

226.2

5158

34528

R5599

NOMESCO Finland

Other rehabilitation service

4.4

220.4

578

1373

N06AX21

ATC

duloxetine; oral

2.4

219.7

1804

8330

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

215.6

3208

18634

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.3

214.5

869

2782

A91

ICPC

Abnormal result investigation NOS

3.2

211.9

877

2844

WX320

NOMESCO Finland

Spinalanesthesy

1.9

210.4

3395

20242

WX002

NOMESCO Finland

Sedation and analgesia

2.0

210.3

2820

15774

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.9

201.7

3109

18214

SBA00, ,

SPAT

67.5

195.8

107

A27

ICPC

Fear of other disease NOS

3.1

195.0

866

2925

Z2446

NOMESCO Finland

Social worker

2.8

194.7

1023

3795

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

193.8

4187

27241

ZX120

NOMESCO Finland

Intravenous

2.4

193.2

1461

6481

A01

ICPC

Pain general/multiple sites

2.4

192.4

1433

6312

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

190.3

2798

16087

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

183.8

2051

10668

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.2

182.9

1796

8888

L28

ICPC

Limited function/disability (L)

2.0

179.3

2551

14466

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

176.4

1847

9364

XCW10

NOMESCO Finland

Assessment of vision

5.6

174.9

335

609

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.8

174.7

941

3532

A02BC02

ATC

pantoprazole; systemic

1.8

169.4

8616

70153

XF600

NOMESCO Finland

Bloodpressure measurement

2.7

166.9

997

3943

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

165.0

1528

7364

U07.2

ICD-10 Finland

COVID-19, virus not identified

2.0

164.2

2262

12645

SPAT1285

SPAT

Provision of consultation response

2.8

164.0

865

3208

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.5

161.0

1155

4984

WVA20

NOMESCO Finland

Medicine administration

3.9

160.3

483

1269

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

159.5

3832

25395

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.5

159.2

1054

4380

Z71.8

ICD-10 Finland

Other specified counselling

1.7

157.7

3844

25560

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.4

157.4

596

1824

N02BE01

ATC

paracetamol; systemic, rectal

2.2

155.2

11094

98715

WX402

NOMESCO Finland

General anaesthesia

1.8

154.8

2742

16595

ZXE20

NOMESCO Finland

More than three and less than five hours

2.0

152.5

1869

10005

M01AB05

ATC

diclofenac; systemic, rectal

1.7

151.8

8122

65942

WX111

NOMESCO Finland

Local infiltration anesthesia

3.2

150.8

630

2047

ZXD20

NOMESCO Finland

Day surgery

2.0

150.2

1782

9423

Z46.6

ICD-10 Finland

Fitting and adjustment of urinary device

26.6

150.2

103

WW200, ,

SPAT

0.4

147.3

851

19234

M48.0

ICD-10 Finland

Spinal stenosis

2.0

147.2

1771

9407

R4130

NOMESCO Finland

Speech therapy

3.8

146.5

459

1239

L17

ICPC

Foot/toe symptom/complaint

1.7

146.2

3708

24820

Z02.7

ICD-10 Finland

Issue of medical certificate

2.4

145.4

1044

4499

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.5

144.7

985

4141

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.1

144.7

1476

7370

M01AH05

ATC

etoricoxib; oral

1.6

144.6

7543

60459

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

144.2

1626

8432

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

142.6

5543

41299

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

6.5

141.1

232

363

TUPEI, ,

NOMESCO Finland

3.2

140.3

584

1892

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.7

137.4

780

2999

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.5

137.1

336

755

Z65.9

ICD-10 Finland

Problem related to unspecified psychosocial circumstances

25.6

135.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

134.9

2132

12387

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.1

134.5

1450

7383

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

132.9

3035

19649

ZXD05

NOMESCO Finland

Urgent procedure

1.7

132.7

3704

25294

AN1

Coronary angiography

2.1

132.5

1510

7844

EAV, ,

NOMESCO Finland

4.4

131.5

336

780

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.7

130.8

763

2973

ZXD35

NOMESCO Finland

Usual procedure

3.2

130.3

540

1744

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.2

128.6

526

1686

H02AB07

ATC

prednisone; oral

1.9

126.9

1829

10298

K22

ICPC

Risk factor cardiovascular disease

2.5

126.7

864

3629

N03AX12

ATC

[U] gabapentin; oral

1.8

124.0

2152

12838

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.0

121.9

1532

8227

S21

ICPC

Skin texture symptom/complaint

1.9

120.6

1859

10681

L84

ICPC

Back syndrome without radiat pain

2.6

120.5

715

2808

A28

ICPC

Limited function/disability NOS

1.8

120.3

2251

13721

XF600, ,

SPAT

3.3

119.6

459

1414

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

4.5

119.1

294

664

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.4

119.1

451

1378

M01AH01

ATC

celecoxib; oral

1.8

118.1

2341

14503

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.3

117.2

918

4100

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

6.6

116.3

188

289

BEF00, ,

SPAT

8.1

116.1

156

195

R52.9

ICD-10 Finland

Pain, unspecified

2.0

114.4

1318

6853

L12

ICPC

Hand/finger symptom/complaint

1.8

113.1

2035

12240

KMAK, ,

NOMESCO Finland

1.5

112.9

5890

46061

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

112.8

936

4282

XF404

NOMESCO Finland

Ambulatory ECG

2.1

112.8

1207

6108

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

6.6

112.1

182

281

SPAT1310

SPAT

Counselling related to known health issue

0.5

111.4

1710

27938

A02BC05

ATC

esomeprazole; systemic

1.5

110.8

5000

37841

XF602

NOMESCO Finland

Bloodpressure monitoring

4.9

110.4

247

515

XCH00

NOMESCO Finland

Eye pressure measurement

2.5

110.1

719

2955

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

109.8

1844

10856

J45.1

ICD-10 Finland

Nonallergic asthma

2.2

109.5

997

4737

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

109.1

4352

32023

ZXA10

NOMESCO Finland

Bilateral

1.7

108.7

2385

15156

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

108.7

5006

38002

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

107.5

4527

33682

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

107.3

3101

21149

-64

ICPC

Encounter/prob initiated by provider

4.1

104.4

290

717

S29

ICPC

Skin symptom/complaint other

1.7

103.8

2370

15201

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

3.1

103.1

454

1518

M01AH02

ATC

rofecoxib; oral

1.8

102.6

1672

9737

SPAT1324

SPAT

Screening procedure

1.8

101.4

1930

11765

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.2

101.0

925

4401

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

100.5

1961

12037

UDC00, ,

SPAT

31.1

99.6

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

99.6

1960

12057

X58

ICD-10 Finland

Exposure to other specified factors

1.8

98.9

1689

9968

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

9.4

98.9

118

127

F21, ,

ICPC

5.7

98.2

185

331

XF402

NOMESCO Finland

ECG with work load test

1.9

97.8

1379

7664

Catheterization and pressure measurement of the left side of the heart

4.0

97.5

278

701

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

96.8

2269

14624

L88

ICPC

Rheumatoid/seropositive arthritis

2.6

96.0

602

2425

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

5.8

96.0

176

307

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

95.9

3392

24142

B01AB10

ATC

tinzaparin; parenteral

1.9

95.8

1295

7094

TQW40

NOMESCO Finland

Remowal of suture of skin

2.1

95.8

957

4707

M79.6

ICD-10 Finland

Pain in limb

1.5

95.5

4979

38468

Z12.4

ICD-10 Finland

Special screening examination for neoplasm of cervix

3.3

95.4

364

1117

M54.4

ICD-10 Finland

Lumbago with sciatica

1.7

95.0

2158

13786

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

94.1

2943

20347

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

7.5

93.8

134

180

Z00.8

ICD-10 Finland

Other general examinations

2.1

93.3

993

5000

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.4

93.0

664

2840

D82

ICPC

Teeth/gum disease

0.6

92.9

2105

31364

J01DB01

ATC

cefalexin; oral

1.6

92.5

9919

88511

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

91.7

1064

5528

UJF32

NOMESCO Finland

Coloscopy

1.6

90.5

3192

22648

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.3

89.6

688

3038

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.2

89.6

833

3982

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

89.1

1704

10370

Z2445

NOMESCO Finland

Psychologist

2.7

88.7

493

1869

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

88.7

3393

24486

M25.5

ICD-10 Finland

Pain in joint

1.5

88.4

3727

27454

J01MA02

ATC

ciprofloxacin; systemic

1.5

87.2

4598

35410

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.5

86.7

308

903

M54.5

ICD-10 Finland

Low back pain

1.5

86.6

4165

31485

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

86.5

1282

7223

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

86.2

874

4318

N05CF01

ATC

zopiclone; oral

1.5

84.7

3849

28737

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.4

84.5

306

908

R03BA02

ATC

budesonide; inhalant

1.6

84.4

2115

13812

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.9

84.4

416

1481

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

84.1

1327

7622

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.3

84.0

646

2853

XQ845, ,

SPAT

21.1

84.0

XCK00

NOMESCO Finland

Perimetry

2.1

83.8

857

4247

N06AA09

ATC

amitriptyline; systemic

1.9

83.7

1247

7034

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

83.7

1378

8018

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

83.0

3132

22476

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.9

83.0

414

1483

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

82.6

2584

17786

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.5

82.0

514

2068

N02AA05

ATC

oxycodone; systemic

1.6

81.9

2133

14053

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

81.4

1280

7339

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

80.7

911

4679

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

80.5

4199

32135

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

80.1

699

3255

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

79.7

2250

15105

D01

ICPC

Abdominal pain/cramps general

1.8

78.4

1371

8111

A02BC01

ATC

omeprazole; systemic

1.5

78.2

3219

23475

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

77.9

600

2651

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

77.8

596

2627

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

3.6

77.4

257

721

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

77.2

995

5348

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.8

77.2

388

1395

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.7

77.1

1787

11416

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

77.0

1370

8142

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.7

77.0

246

672

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

77.0

630

2855

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

77.0

8188

71148

C07AB07

ATC

bisoprolol; oral

1.4

76.8

5732

46739

Z46.7

ICD-10 Finland

Fitting and adjustment of orthopaedic device

11.3

76.7

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.9

76.6

228

593

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.1

76.6

808

4047

R51.80

ICD-10 Finland

Headache

1.7

76.2

1747

11128

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.7

76.1

240

650

WZC00, ,

SPAT

1.8

76.0

1192

6822

L20

ICPC

Joint symptom/complaint NOS

2.5

76.0

507

2100

Z50.5

ICD-10 Finland

Speech therapy

4.0

75.7

218

554

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.4

75.6

275

819

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.5

75.1

470

1889

H02AB06

ATC

prednisolone; systemic

1.4

74.6

5556

45196

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

74.6

3128

22856

M03BX01

ATC

baclofen; systemic

3.3

74.3

281

857

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

74.1

970

5240

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

73.7

2185

14806

M54.1

ICD-10 Finland

Radiculopathy

2.4

73.6

538

2323

M03BX02

ATC

tizanidine; oral

1.4

73.5

7075

60122

PD4HE

NOMESCO Finland

Postoperative lower extremity artery ultrasound examination with Doppler method

13.0

73.3

J01FF01

ATC

clindamycin; systemic

1.5

73.2

3105

22725

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.5

73.2

488

2021

C03CA01

ATC

furosemide; systemic

1.5

72.7

3515

26388

R05

ICPC

Cough

1.5

72.2

2753

19705

A10AE04

ATC

insulin glargine; parenteral

1.8

72.1

1133

6484

L04AX03

ATC

methotrexate; systemic

1.8

71.9

1164

6722

R52.2

ICD-10 Finland

Other chronic pain

2.4

71.9

491

2056

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

71.8

912

4875

ZY010

NOMESCO Finland

Hospital outpatient

2.3

71.6

584

2642

K07

ICPC

Swollen ankles/oedema

2.2

71.6

627

2921

N06AX16

ATC

venlafaxine; oral

1.7

71.5

1580

9956

SPAT1151

SPAT

Treatment of major wounds

3.9

71.3

209

538

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

71.1

4056

31381

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

70.9

523

2267

UKC02

NOMESCO Finland

Cystoscopy

1.6

70.6

1837

12056

CS2P4

NOMESCO Finland

Optic nerve head imaging

4.6

70.5

167

365

M01AX05

ATC

glucosamine; oral

1.5

70.4

2375

16549

XX9XE

NOMESCO Finland

Other ultrasound examination

4.6

69.8

168

372

L01BA01

ATC

methotrexate; systemic

2.4

69.7

501

2146

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.2

69.3

649

3104

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

69.2

893

4796

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

69.2

693

3401

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

3.1

69.2

290

942

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

68.8

4232

33137

A10AB05

ATC

insulin aspart; parenteral

1.9

68.5

909

4927

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

67.8

1461

9135

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.4

67.3

484

2073

L04AA13

ATC

[U] leflunomide

2.7

67.3

365

1366

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

67.2

1147

6722

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

67.2

1485

9347

K85

ICPC

Elevated blood pressure

1.6

66.9

1917

12857

R06.0

ICD-10 Finland

Dyspnoea

1.5

66.9

3095

22971

Z47.8

ICD-10 Finland

Other specified orthopaedic follow-up care

5.3

66.7

133

251

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

66.7

2807

20448

A13

ICPC

Concern/fear medical treatment

3.1

66.4

282

923

R03DC03

ATC

montelukast; oral

1.6

65.5

1883

12634

K07.60

ICD-10 Finland

Snapping jaw

2.2

65.3

585

2749

A06AD11

ATC

lactulose; oral

1.6

64.4

1695

11135

M01AC06

ATC

meloxicam; systemic, rectal

1.4

64.2

4189

33037

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

4.7

63.9

148

318

A10AE05

ATC

insulin detemir; parenteral

2.1

63.5

639

3141

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

63.3

1183

7111

VALMI, ,

NOMESCO Finland

1.5

62.9

2619

19003

M35.7

ICD-10 Finland

Hypermobility syndrome

3.7

62.8

199

541

N02BF02

ATC

pregabalin; oral

2.0

62.5

708

3633

A07AA02

ATC

nystatin; oral

2.0

62.3

739

3855

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.8

62.1

1085

6396

D06

ICPC

Abdominal pain localized other

1.8

62.0

1007

5810

L86

ICPC

Back syndrome with radiating pain

2.0

61.9

743

3890

J01MA12

ATC

levofloxacin; systemic

1.5

61.9

2106

14652

M02AA07

ATC

piroxicam; topical

1.4

61.7

4144

32789

U02

ICPC

Urinary frequency/urgency

1.6

61.6

1649

10868

KC1EE, ,

SPAT

6.6

61.0

150

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.8

60.9

184

484

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

60.7

3035

22783

A11

ICPC

Chest pain NOS

1.8

60.5

983

5671

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.1

60.4

593

2887

B88.0

ICD-10 Finland

Other acariasis

6.9

60.4

136

M01AB55

ATC

diclofenac, combinations; oral

1.9

60.0

834

4584

A10BA02

ATC

metformin; oral

1.4

60.0

3168

24008

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.0

60.0

273

930

R53

ICD-10 Finland

Malaise and fatigue

1.5

59.9

2667

19579

A04

ICPC

Weakness/tiredness general

1.6

59.9

1670

11107

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.0

59.8

693

3585

-50

ICPC

Medication/prescr/renewal

2.2

59.5

518

2405

E66.8

ICD-10 Finland

Other obesity

2.1

59.4

620

3088

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

6.7

59.2

142

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.8

58.9

1008

5903

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.2

58.9

515

2396

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.6

58.7

347

1356

N06AB10

ATC

escitalopram; oral

1.5

58.7

2148

15159

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

58.7

1449

9359

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

58.6

2170

15349

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

58.3

1125

6815

OSTO, ,

NOMESCO Finland

4.1

58.1

158

385

XA420

NOMESCO Finland

Extensive sleep examination

3.9

58.0

171

442

L13

ICPC

Hip symptom/complaint

1.5

58.0

2122

14968

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

57.9

1143

6968

QCB10, ,

SPAT

4.9

57.8

127

261

B01AB04

ATC

dalteparin; parenteral

2.0

57.5

649

3324

-44

ICPC

Preventive immunization/medic

1.8

57.5

963

5602

L15

ICPC

Knee symptom/complaint

1.4

57.5

2700

20000

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

57.4

475

2161

F29

ICPC

Eye symptom/complaint other

1.7

57.2

1088

6562

N06AX11

ATC

mirtazapine; oral

1.4

57.2

3810

30008

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.5

56.8

473

9625

OAB50, ,

SPAT

2.0

56.8

665

3450

D11

ICPC

Diarrhoea

1.7

56.7

1246

7811

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

56.6

1284

8114

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

56.6

837

4690

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.4

56.5

400

1701

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

0.4

56.3

247

6510

M01AE02

ATC

naproxen; oral, rectal

1.3

56.2

6296

53750

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.1

56.1

239

784

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

56.0

440

1958

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.8

55.8

286

1039

U05

ICPC

Urination problems other

2.0

55.7

613

3111

ACC51

NOMESCO Finland

Release of median nerve

1.8

55.7

886

5075

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.3

55.7

456

2065

Z36.4

ICD-10 Finland

Antenatal screening for fetal growth retardation using ultrasound and other physical methods

4.3

55.6

142

330

W19

ICD-10 Finland

Unspecified fall

1.7

55.5

1122

6878

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

55.5

1303

8304

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.6

55.0

320

1241

SPAT1059

SPAT

Spirometry at the office

2.0

55.0

615

3140

R03AC03

ATC

terbutaline; inhalant

1.6

54.9

1565

10444

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

54.9

525

2529

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

54.9

467

2149

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.0

54.6

637

3301

S01BC05

ATC

ketorolac; ophthalmic

2.2

54.5

469

2167

R52.1

ICD-10 Finland

Chronic intractable pain

4.1

54.2

149

366

R02

ICPC

Shortness of breath/dyspnoea

1.6

54.1

1478

9765

N06AA12

ATC

doxepin; systemic

2.0

54.1

628

3248

-59

ICPC

Other therap proced/minor surg NEC

2.5

54.1

353

1447

A08

ICPC

Swelling

2.0

53.8

629

3261

-65

ICPC

Enc/prob init by other than pt/prov

5.3

53.7

107

202

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

53.2

747

4117

XQ845

NOMESCO Finland

Dermatoscopy

2.9

53.1

255

895

ZB0.1

ICD-10 Finland

Right side

12.4

52.9

XA400

NOMESCO Finland

EEG

5.0

52.9

113

227

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

8.0

52.8

CLA10, ,

SPAT

8.9

52.7

N05AH04

ATC

quetiapine; oral

1.5

52.5

1823

12695

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

52.5

1004

6061

J01CF05

ATC

flucloxacillin; systemic

1.9

52.2

684

3686

A02BA02

ATC

ranitidine; systemic

1.5

52.1

2171

15683

D12

ICPC

Constipation

2.2

51.9

436

1995

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

0.3

51.5

189

5424

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.8

51.3

265

967

TMW99

NOMESCO Finland

Other minor surgical procedure in obstetrics

6.5

51.3

128

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.1

51.3

503

2447

J01AA02

ATC

doxycycline; systemic

1.4

51.2

9031

81993

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

51.2

7025

61409

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.7

51.1

950

5687

R29

ICPC

Respiratory symptom/complaint other

1.8

51.1

759

4255

XF606

NOMESCO Finland

Ortostatic test

4.4

51.1

127

289

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.8

51.0

869

5076

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

51.0

437

2016

R52.0

ICD-10 Finland

Acute pain

2.3

50.9

390

1717

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

50.9

424

1934

T93

ICPC

Lipid disorder

1.8

50.9

773

4365

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

0.7

50.4

1854

25585

XCW10, ,

SPAT

5.2

50.4

103

199

L14

ICPC

Leg/thigh symptom/complaint

1.7

50.2

915

5448

LASKU, ,

NOMESCO Finland

4.1

50.0

136

332

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

49.8

916

5466

N17

ICPC

Vertigo/dizziness

1.6

49.8

1385

9178

A62

ICPC

General and Unspecified, Administrative procedure

2.5

49.8

322

1314

-1, ,

NOMESCO Finland

1.4

49.7

3462

27324

N05BA01

ATC

diazepam; systemic, rectal

1.6

49.6

1437

9611

R42

ICD-10 Finland

Dizziness and giddiness

1.4

49.6

2600

19570

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

49.5

425

1963

L04AB01

ATC

etanercept; parenteral

3.1

49.4

213

704

WX199

NOMESCO Finland

Other local analgesia

2.2

49.2

418

1921

K29

ICPC

Cardiovascular sympt/complt other

2.0

49.2

532

2683

N06AB04

ATC

citalopram; systemic

1.4

49.0

2287

16854

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.4

49.0

174

511

S80.0

ICD-10 Finland

Contusion of knee

1.8

49.0

806

4660

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.7

48.9

273

1037

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

3.3

48.4

185

569

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

48.4

2136

15575

Y83.1

ICD-10 Finland

Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

48.3

215

724

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

48.2

1544

10553

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

48.2

557

2875

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.3

48.2

123

286

D18

ICPC

Change in faeces/bowel movements

2.5

48.1

311

1269

L03

ICPC

Low back symptom/complaint

1.4

48.0

3003

23270

M24.2

ICD-10 Finland

Disorder of ligament

3.3

48.0

185

572

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

47.9

599

3176

RT271, ,

NOMESCO Finland

8.7

47.8

R03AC02

ATC

salbutamol; inhalant

1.3

47.8

6085

52397

WX144

NOMESCO Finland

Subconjunctival anesthesy

3.6

47.7

156

434

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.4

47.6

339

1446

N29

ICPC

Neurological sympt/complt other

2.7

47.2

254

947

R07.3

ICD-10 Finland

Other chest pain

1.6

47.1

1139

7296

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

47.1

640

3487

R03BA05

ATC

fluticasone; inhalant

1.5

47.1

1956

14088

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.3

47.0

375

1680

R13

ICD-10 Finland

Dysphagia

1.8

47.0

787

4573

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

46.8

1458

9904

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.1

46.7

472

2321

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

3.8

46.6

141

372

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.9

46.5

578

3058

A80

ICPC

Trauma/injury NOS

3.3

46.5

174

528

L04AB04

ATC

adalimumab; parenteral

2.7

46.4

259

984

M54.3

ICD-10 Finland

Sciatica

1.8

46.2

693

3895

FL1AC

NOMESCO Finland

Left cardioangiography

2.8

46.2

228

813

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

46.1

899

5448

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.9

46.0

218

760

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

45.9

345

1506

U07

ICPC

Urine symptom/complaint other

1.7

45.8

845

5045

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

4.1

45.7

124

302

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.0

45.7

508

2587

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.6

45.6

1255

8286

A99

ICPC

Disease/condition unspecnature/site

1.6

45.6

1031

6493

B01AF01

ATC

rivaroxaban; oral

1.5

45.6

1424

9671

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

45.5

1084

6916

M43.1

ICD-10 Finland

Spondylolisthesis

2.0

45.5

483

2419

L04

ICPC

Chest symptom/complaint

1.8

45.4

694

3922

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

45.4

1856

13320

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

3.1

45.4

193

633

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.1

45.3

467

2313

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

45.3

6044

52214

SPAT1104

SPAT

Monitoring of emergency patient

0.3

45.3

150

4533

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

3.0

45.2

200

671

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.0

45.2

518

2666

P01AB01

ATC

metronidazole; oral, rectal

1.3

45.2

4381

36217

ZB0.0

ICD-10 Finland

Left side

15.6

45.1

N03AX09

ATC

lamotrigine; oral

2.0

45.0

486

2449

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.6

44.9

263

1024

K30

ICD-10 Finland

Functional dyspepsia

1.6

44.7

1221

8046

RS221, ,

NOMESCO Finland

3.1

44.7

191

628

J01MA14

ATC

moxifloxacin; systemic

1.7

44.7

981

6133

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

44.7

5052

42647

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

2.7

44.6

240

895

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

44.6

668

3752

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.4

44.4

325

1403

K28

ICPC

Limited function/disability (K)

2.5

44.3

281

1137

K08.9

ICD-10 Finland

Disorder of teeth and supporting structures, unspecified

7.8

44.1

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

44.0

2195

16331

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

44.0

832

5000

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

5.4

43.7

157

SPAT1161

SPAT

Ultrasound examination of urinary bladder

5.3

43.7

168

N01

ICPC

Headache

1.6

43.3

1077

6942

D02

ICPC

Abdominal pain epigastric

1.8

43.2

677

3855

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

3.2

43.0

173

549

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.9

43.0

128

334

J01FA06

ATC

roxithromycin; oral

1.3

42.9

4348

36093

R35

ICD-10 Finland

Polyuria

1.7

42.5

738

4329

L05

ICPC

Flank/axilla symptom/complaint

1.8

42.3

668

3811

R06.5

ICD-10 Finland

Mouth breathing

1.6

42.2

930

5818

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

42.2

706

4099

RD211, ,

NOMESCO Finland

0.2

41.8

2678

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

41.8

922

5768

ZX120, ,

SPAT

3.5

41.7

141

401

R96

ICPC

Asthma

1.6

41.7

1058

6848

R33

ICD-10 Finland

Retention of urine

1.7

41.7

809

4894

L02

ICPC

Back symptom/complaint

1.6

41.3

1037

6697

L09

ICPC

Arm symptom/complaint

1.9

41.2

532

2850

J02AC01

ATC

fluconazole; systemic

1.3

41.1

4245

35275

S97

ICPC

Chronic ulcer skin

1.8

41.0

670

3861

B82

ICPC

Anaemia other/unspecified

2.3

40.9

325

1453

TNE11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in sacroiliac joint

90.4

40.8

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

40.8

4086

33801

B01AC04

ATC

clopidogrel; oral

1.4

40.8

1751

12662

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

40.7

647

3699

WX204

NOMESCO Finland

Axillary plexus blockaced

2.1

40.5

379

1811

M53.2

ICD-10 Finland

Spinal instabilities

3.8

40.4

123

326

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

40.3

256

1037

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.7

40.1

127

346

TUPKY, ,

NOMESCO Finland

3.9

40.1

117

301

S18

ICPC

Laceration/cut

1.3

39.9

5043

42986

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

39.4

1213

8201

ZX100

NOMESCO Finland

Oral

2.9

39.2

186

649

S04

ICPC

Lump/swelling localized

1.6

39.2

1086

7172

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

39.2

1446

10149

L91

ICPC

Osteoarthrosis other

2.5

39.2

245

985

Y96.9

ICD-10 Finland

Unspecified type of accident

2.6

39.2

231

903

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

39.1

873

5474

P01BA02

ATC

hydroxychloroquine; oral

1.6

39.1

914

5797

M01AX01

ATC

nabumetone; oral

1.9

39.1

486

2571

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

0.4

39.1

153

4266

A92

ICPC

Allergy/allergic reaction NOS

2.3

39.1

307

1367

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

38.9

695

4109

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.0

38.9

461

2401

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

38.9

464

2422

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

4.3

38.7

100

235

M89.0

ICD-10 Finland

Algoneurodystrophy

3.7

38.7

123

336

WX212

NOMESCO Finland

Femoral plexus blockade

2.3

38.6

285

1236

R06AX22

ATC

ebastine; oral

1.4

38.2

1760

12876

J01FA09

ATC

clarithromycin; systemic

1.3

38.2

3320

26872

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

38.1

1064

7036

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

38.0

661

3879

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.8

37.8

3152

38507

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.6

37.8

122

337

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

37.6

1192

8103

N06AB06

ATC

sertraline; oral

1.5

37.6

1117

7488

RT272, ,

NOMESCO Finland

5.7

37.6

121

L76

ICPC

Fracture: other

2.1

37.5

361

1743

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

37.4

379

1866

R03BB04

ATC

tiotropium bromide; inhalant

1.6

37.4

1060

7034

NGA20

NOMESCO Finland

Exploration of soft tissue knee or lower leg, open

6.7

37.3

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

2.8

37.2

184

657

M54.2

ICD-10 Finland

Cervicalgia

1.6

37.2

823

5149

C08CA01

ATC

amlodipine; oral

1.3

37.2

4236

35528

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.9

37.2

488

2629

ZZH40

NOMESCO Finland

Substitute of bone

3.4

37.1

135

403

R83

ICPC

Respiratory infection other

1.4

37.1

2396

18546

RJ120, ,

NOMESCO Finland

9.4

37.1

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

36.9

2557

20000

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.8

36.9

589

3371

G04BD08

ATC

solifenacin; oral

1.7

36.7

742

4534

C10AA05

ATC

atorvastatin; oral

1.3

36.6

4589

38941

S83.2

ICD-10 Finland

Tear of meniscus, current

1.7

36.6

717

4347

J01EA01

ATC

trimethoprim; systemic

1.3

36.5

2848

22667

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

36.5

669

3983

R01AD09

ATC

mometasone; nasal

1.3

36.5

4792

40898

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.4

36.4

243

1007

Z29

ICPC

Social problem NOS

2.5

36.2

235

962

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

2.4

36.0

255

1086

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

36.0

4260

35866

ZYC01, ,

SPAT

0.5

35.9

290

6003

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

35.8

825

5213

P74

ICPC

Anxiety disorder/anxiety state

2.0

35.8

392

1986

R4190

NOMESCO Finland

Nutritional therapy

2.0

35.6

391

1982

ZXH06, ,

SPAT

0.2

35.5

2739

J45.8

ICD-10 Finland

Mixed asthma

2.1

35.5

353

1726

N05BA12

ATC

alprazolam; oral

1.5

35.5

1052

7048

P25

ICPC

Phase of life problem adult

2.0

35.3

399

2044

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

35.1

2613

20636

P01

ICPC

Feeling anxious/nervous/tense

1.5

35.1

1011

6728

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022096) Basophils/100 leukocytes in Blood

6864

46748

2.05

322.08

7.9

6.1

0.67

0.68

0.40

6625

43366

(3016750) Collection duration of Urine

409

484

8.71

319.00

2.3

2.2

495.10

499.73

min

0.36

397

330

(3018010) Neutrophils/100 leukocytes in Blood

7080

49036

2.04

313.70

8.0

5.9

58.17

57.30

8.13

6859

45740

(3004775) Volume in Urine collected for unspecified duration

556

684

8.46

307.65

2.9

2.2

589.33

670.86

4.01

498

418

(3035285) Chloride [Moles/volume] in Venous blood

1028

1114

9.97

307.65

2.7

2.3

105.75

105.44

mmol/l

0.91

1019

1102

(3026782) Osmolality of Urine

4534

20585

2.90

307.65

4.2

2.9

569.15

534.67

mosm/kgh2o

18.20

4155

17573

(3027273) Bicarbonate [Moles/volume] in Venous blood

1750

4757

4.12

307.65

4.5

3.5

25.54

25.21

mmol/l

3.33

1726

4610

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1559

5322

3.21

307.65

2.8

0.19

0.29

e6/l

2.85

1538

5182

(3003338) MCHC [Mass/volume]

11625

85429

7.10

307.65

26.6

18.8

331.58

331.97

g/l

4.75

11558

84781

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4203

20051

2.66

307.65

4.1

3.8

220.24

475.72

ng/l

3.99

3248

15770

(3029937) Albumin [Presence] in Urine by Test strip

671

28264

0.19

307.65

3.7

4.2

0.01

0.00

estimate

0.61

161

9365

(1761482) Bacteria [#/volume] in Urine by Culture

1890

2318

9.45

307.65

4.7

4.2

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2756

9332

3.51

307.65

4.6

4.1

5.74

5.85

kpa

6.68

2705

9050

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1738

4381

4.45

307.65

5.7

3.9

45.55

48.48

4.75

1716

4328

(3004119) Hemoglobin [Mass/volume] in Venous blood

2052

5973

3.92

307.65

3.9

3.5

129.61

128.17

g/l

2.07

2028

5828

(3002582) Erythrocytes [#/volume] in Urine

6197

31190

2.98

307.65

4.3

3.2

44.93

90.25

e6/l

4.60

5344

23747

(3041354) Potassium [Moles/volume] in Venous blood

1029

1114

9.99

307.65

2.7

2.3

4.10

4.05

mmol/l

2.33

1021

1102

(3000330) Specific gravity of Urine by Test strip

3012

4680

8.19

307.65

4.5

3.4

—

(3008037) Lactate [Moles/volume] in Venous blood

1534

1964

8.78

307.65

3.9

3.1

1.56

1.63

mmol/l

1.50

1516

1914

(3000850) Epithelial cells [#/volume] in Urine

4036

21874

2.26

307.65

3.5

2.6

5.65

5.63

e6/l

0.03

3752

19553

(3038515) Glucose [Moles/volume] in Venous blood

1532

1842

9.35

307.65

3.9

3.3

7.48

7.60

mmol/l

0.62

1515

1800

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1494

4586

3.57

307.65

2.8

3.0

0.68

0.65

3.72

1480

4565

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4056

17583

2.95

307.65

3.2

2.8

1.27

1.32

e6/l

0.08

2973

9873

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4030

16193

3.21

307.65

3.3

3.0

2.83

2.70

e6/l

0.34

2937

8560

(3018095) Leukocytes [#/volume] in Urine

6621

36465

2.76

307.65

4.8

3.7

97.59

103.70

e6/l

0.28

5417

25664

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5555

32910

2.25

307.65

3.1

3.3

33.34

34.72

u/l

0.56

5371

31087

(3002032) Base excess in Venous blood by calculation

2787

9287

3.58

307.65

4.6

4.1

2.20

1.94

mmol/l

3.62

2364

7881

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2156

8841

2.74

307.65

3.3

2.9

199.91

201.11

ng/l

0.03

1927

8072

(3021589) Normoblasts [#/volume] in Blood

7155

45020

2.40

307.65

9.8

0.00

e9/l

0.08

6217

36631

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1028

1091

10.19

307.65

2.7

2.3

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1497

4697

3.49

307.65

2.8

3.0

1.11

1.26

6.12

1480

4672

(36304419) Bacteria [Presence] in Urine

5023

27956

2.34

307.65

4.2

3.1

—

(3030467) Casts [#/volume] in Urine by Automated count

5824

28597

2.96

307.65

4.3

3.1

0.29

0.46

e6/l

8.86

4986

21613

(3024354) Oxygen [Partial pressure] in Venous blood

2491

7613

3.85

307.65

4.1

3.4

4.56

4.58

kpa

0.12

2445

7351

(3002030) Lymphocytes/100 leukocytes in Blood

7122

49798

2.02

302.73

8.0

6.1

26.95

27.74

8.12

6881

46504

(3006504) Eosinophils/100 leukocytes in Blood

6957

48309

2.01

300.83

7.9

6.0

2.82

2.86

0.65

6701

44917

(3019069) Monocytes/100 leukocytes in Blood

6952

48593

1.98

291.04

8.0

6.4

8.62

8.61

0.06

6696

45274

(3002385) Erythrocyte distribution width [Ratio]

10617

87795

2.49

271.48

27.3

17.2

13.81

15.13

110.40

10530

86214

(3007930) Methemoglobin/Hemoglobin.total in Blood

1198

4126

3.11

263.12

3.8

5.3

0.78

0.90

25.61

1172

3859

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

127

13361

0.09

262.69

3.5

4.6

30.97

32.72

1.20

106

9094

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1204

4181

3.08

260.61

3.8

5.2

1.46

1.65

8.01

1178

3907

(40758558) Short blood count panel - Blood

4272

26287

1.96

249.01

9.1

6.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

183

13629

0.12

245.03

4.4

7.2

—

(3026008) Bacteria identified in Urine by Culture

4983

33118

1.85

222.63

3.9

3.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2830

15947

2.00

206.16

2.1

29.94

29.87

0.26

2781

15465

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1947

9582

2.22

202.58

2.8

2.5

39.63

43.07

u/l

0.16

1678

8170

(3037467) Urinalysis macro (dipstick) panel - Urine

8868

71348

1.86

199.88

5.9

4.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3658

22659

1.87

199.72

2.0

1.7

1.21

1.22

mg/l

0.09

3034

17309

(3044640) Blood type and Crossmatch panel - Blood

4850

33021

1.77

191.88

2.6

2.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7011

52972

1.75

191.77

7.8

6.7

1.22

1.21

mmol/l

12.43

6779

44689

(3022217) INR in Platelet poor plasma by Coagulation assay

6591

49067

1.74

188.88

14.5

15.5

1.34

1.27

inr

0.62

1596

14132

(3013650) Neutrophils [#/volume] in Blood by Automated count

7695

59968

1.75

185.75

11.2

9.1

4.21

4.11

e9/l

3.36

6959

52151

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5930

43159

1.72

181.84

2.2

2.0

91.67

96.04

pmol/l

12.51

3271

22137

(3013826) Glucose [Moles/volume] in Serum or Plasma

7787

61108

1.74

181.03

5.5

4.7

6.94

6.72

mmol/l

10.61

7361

57289

(3013115) Eosinophils [#/volume] in Blood

7004

53544

1.71

177.43

7.9

6.0

0.19

e9/l

1.95

6381

46677

(3019198) Lymphocytes [#/volume] in Blood

6957

53170

1.71

175.63

7.8

5.9

1.89

1.92

e9/l

0.84

6322

46744

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1347

6006

2.39

175.23

1.6

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

9279

76987

1.82

173.51

5.0

4.1

12.84

12.68

mm/h

0.49

9022

71018

(3033658) Prothrombin time (PT) actual/Normal

3994

26408

1.76

169.88

5.0

3.9

89.61

89.87

0.26

3938

25726

(3006315) Basophils [#/volume] in Blood

6787

51872

1.68

168.11

7.7

5.8

0.04

e9/l

2.73

6101

44564

(3001604) Monocytes [#/volume] in Blood

6772

51738

1.68

167.88

7.7

5.8

0.60

0.59

e9/l

3.97

6045

44495

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

614

1855

3.43

165.59

2.2

1.8

0.82

0.81

nmol/l

0.04

551

1544

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

943

3733

2.65

157.32

2.1

2.3

9.97

10.20

g/l

0.81

885

3261

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6368

48456

1.65

155.28

2.9

2.6

—

(3013512) EKG study

4388

30536

1.68

150.39

5.6

3.9

—

(3006270) Folate [Moles/volume] in Blood

370

840

4.51

149.06

1.2

281.86

358.06

nmol/l

9.18

270

712

(40761536) Microorganisms panel - Urine sediment

144

9006

0.15

146.96

3.7

4.1

—

(3042936) Bacteria identified in Isolate by Culture

2450

14569

1.85

145.20

2.5

2.0

—

(3028626) Oxygen [Partial pressure] in Capillary blood

683

2378

2.98

145.00

3.6

3.3

8.02

8.22

kpa

1.99

675

2316

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

959

4011

2.51

142.38

2.2

2.3

3.74

3.67

g/l

0.81

916

3570

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

959

4015

2.51

142.07

2.1

2.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11364

102763

2.32

141.78

21.8

14.7

23.48

23.91

mg/l

0.71

9774

81884

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

959

4021

2.50

141.60

2.2

2.3

7.57

7.43

g/l

1.80

919

3576

(3022621) pH of Urine by Test strip

1369

6773

2.15

137.01

3.6

3.0

—

(3014051) Protein [Presence] in Urine by Test strip

717

2669

2.79

134.41

2.8

2.5

—

(3007853) Bacteria identified in Skin by Aerobe culture

2096

12245

1.86

129.89

2.1

1.8

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1060

4889

2.28

125.74

4.7

4.5

24.40

24.17

mmol/l

1.48

1042

4788

(4094501) Cardiovascular stress test using bicycle ergometer

696

2653

2.72

124.48

1.2

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

6227

48699

1.56

123.57

7.6

6.4

—

(3000991) Gas panel - Venous blood

1594

8713

1.95

120.35

9.1

8.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3809

26839

1.61

117.15

5.4

3.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

10763

96679

1.88

117.04

19.4

13.7

80.20

79.61

ml/min/173m2

2.12

10046

79782

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9322

80490

1.64

116.87

8.9

7.6

81.79

78.87

u/l

5.72

9088

75719

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

857

3718

2.40

116.83

2.8

3.5

521.58

2083.07

u/ml

1.27

714

3179

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

634

2396

2.74

115.16

2.7

2.2

45.19

112.21

ug/min

7.06

531

1354

(3022948) Iron [Moles/volume] in Serum or Plasma

2583

16554

1.71

114.96

3.0

2.5

12.39

12.84

umol/l

2.64

2482

15345

(3021901) Oxygen saturation in Capillary blood

531

1854

2.95

111.79

2.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2412

15301

1.72

110.95

2.9

2.5

2.31

2.33

g/l

0.73

2327

14082

(3015736) pH of Urine

5319

40949

1.52

107.97

4.6

3.5

5.81

5.86

0.41

268

2849

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6746

54611

1.52

107.87

6.6

6.2

11.32

11.36

umol/l

0.09

6558

51738

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1119

5629

2.09

105.95

2.6

2.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1591

9070

1.87

104.68

7.4

6.9

1.30

1.35

mmol/l

1.38

1563

8813

(3019225) pH of Specimen

411

10993

0.35

99.74

3.9

4.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

11457

106104

2.10

99.33

23.3

16.9

139.66

mmol/l

0.03

11372

103453

(3023368) Bacteria identified in Blood by Culture

3885

28428

1.53

97.08

4.9

4.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

636

2617

2.51

96.95

3.1

3.0

25.33

24.86

mmol/l

1.76

629

2561

(3023103) Potassium [Moles/volume] in Serum or Plasma

11465

106389

2.08

95.91

23.5

17.0

3.96

3.97

mmol/l

2.45

11371

103540

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2216

14401

1.66

90.91

2.9

2.6

21.42

22.29

2.39

2103

12163

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

324

952

3.47

90.91

3.9

3.6

—

(3024928) Oxygen saturation in Venous blood

526

2074

2.60

87.53

3.0

3.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1891

11962

1.69

85.52

2.7

8.32

8.41

umol/l

0.06

1681

10331

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

629

2747

2.36

83.93

2.3

0.00

g/l

-0.00

589

2505

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1025

5447

1.96

82.47

9.3

9.1

24.38

24.34

mmol/l

0.12

1000

5271

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

535

2189

2.51

82.38

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

535

2189

2.51

82.38

1.4

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

5669

45835

1.44

81.29

5.0

4.8

35.55

35.35

g/l

1.75

5433

42456

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

629

2798

2.31

80.39

2.3

2.2

0.00

g/l

0.81

588

2517

(1761868) Lipid panel - Serum or Plasma

4469

34675

1.45

79.44

4.2

2.8

—

(3052851) Hemolysis interference index of Serum or Plasma

676

3198

2.18

74.34

3.0

3.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1794

11601

1.64

73.50

2.0

1.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

6129

50852

1.41

72.77

8.7

5.0

0.00

estimate

1.60

169

9688

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1095

6192

1.84

72.48

1.8

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5368

43584

1.41

71.94

2.5

2.2

78.28

2184.82

nmol/l

0.50

5128

38922

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1784

11583

1.63

71.77

2.0

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

6175

51387

1.40

71.55

4.8

3.8

0.00

estimate

2.43

167

9496

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

7722

66789

1.42

71.47

3.3

3.1

52.11

49.19

u/l

1.72

7428

61859

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

639

3009

2.18

71.05

2.3

2.2

0.02

0.03

g/l

0.50

598

2721

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1745

11298

1.63

70.93

3.4

4.0

14.51

25.52

ug/l

1.45

1455

9170

(3051101) Glucose [Moles/volume] in Cord blood

108

160

6.80

69.24

6.0

6.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1474

9278

1.67

66.63

7.7

7.4

9.97

9.95

mmol/l

0.04

1415

8824

(3035350) Ketones [Presence] in Urine by Test strip

6081

50839

1.39

66.52

4.8

3.8

0.04

0.00

estimate

2.47

434

10246

(3020891) Body temperature

4397

0.17

66.41

4.6

4.8

—

(3037522) Nuclear Ab [Titer] in Serum

2036

13942

1.55

64.66

1.4

1.3

481.03

530.48

titre

0.59

429

2967

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3925

30673

1.41

63.19

3.2

3.0

1547.05

1455.33

ng/l

0.59

3567

26365

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

10320

95022

1.52

62.53

5.2

4.8

1.91

2.12

mu/l

2.77

10061

86702

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1306

8110

1.68

61.90

4.5

3.8

93.79

90.89

ng/l

0.44

1126

6938

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

634

3149

2.07

61.23

2.3

2.1

37.14

37.69

g/l

1.52

589

2697

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11526

109165

1.83

60.88

13.4

10.6

25.79

25.94

u/l

0.31

11412

105072

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

727

3812

1.96

60.31

2.4

2.3

3.07

2.95

g/l

2.51

685

3372

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5306

43839

1.37

60.09

3.3

2.9

134.18

131.15

ug/l

0.27

5087

40353

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1258

7808

1.68

59.62

1.7

1.6

—

(3044941) Cell count panel - Synovial fluid

385

1572

2.50

59.45

1.6

1.4

—

(4034850) Laboratory test

3506

0.13

59.35

6.9

10.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1142

6932

1.71

58.76

2.1

2.4

24.15

24.41

au/ml

0.02

522

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

425

1833

2.37

58.18

4.3

3.6

29.00

38.47

u/ml

1.14

420

1774

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2443

17771

1.47

57.17

1.3

35.69

34.99

iu/ml

0.06

768

5748

(3039162) Centromere protein B Ab [Units/volume] in Serum

329

1271

2.63

56.98

1.2

1.3

62.50

57.34

u/ml

0.11

103

(3000963) Hemoglobin [Mass/volume] in Blood

11840

113534

2.03

54.05

30.4

21.7

133.24

134.59

g/l

20.48

11807

111852

(3007461) Platelets [#/volume] in Blood

11833

113444

2.02

54.04

30.2

21.6

250.79

251.39

e9/l

0.46

11697

110418

(3018418) pH of Serum or Plasma

3963

31649

1.37

53.85

4.9

4.0

7.39

7.40

0.65

113

6216

(3009542) Hematocrit [Volume Fraction] of Blood

11825

113371

2.00

53.52

30.6

21.7

38.35

40.22

45.97

11202

105891

(3024731) MCV [Entitic volume]

11835

113501

2.01

53.50

30.1

21.5

91.18

91.13

0.51

11775

111810

(3035941) MCH [Entitic mass]

11834

113493

2.01

53.42

30.1

21.5

30.30

30.31

0.38

11775

111805

(3026361) Erythrocytes [#/volume] in Blood

11835

113513

2.01

53.30

30.2

21.6

4.43

4.47

e12/l

11.86

11694

110148

(3010813) Leukocytes [#/volume] in Blood

11835

113518

2.01

53.21

30.3

21.6

6.86

6.71

e9/l

9.94

11691

110127

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

565

2849

2.03

52.27

1.4

13.14

14.91

iu/ml

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

758

4220

1.85

52.24

2.1

1.9

1.70

2.30

ug/l

1.09

710

3695

(3014765) Yersinia sp identified in Stool by Organism specific culture

575

2922

2.02

52.06

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

570

2892

2.02

51.83

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3997

32116

1.36

51.72

2.3

2.2

192.86

210.80

u/l

0.63

3830

30010

(42529406) Shigella sp [Presence] in Stool by Culture

575

2932

2.01

51.56

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2269

16565

1.45

51.40

1.6

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

548

2762

2.03

50.75

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

643

3454

1.91

49.49

2.3

0.72

0.90

g/l

0.63

597

2922

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3234

25278

1.38

49.26

2.6

2.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

1280

8366

1.59

48.79

4.1

0.05

0.11

3.42

307

2702

(3000475) Leukocytes [#/volume] in Synovial fluid

507

2525

2.05

48.51

1.7

1.6

11162.95

14192.97

e6/l

0.83

344

1812

(3007164) IgA [Mass/volume] in Serum or Plasma

2561

19319

1.41

48.00

1.5

2.39

2.44

g/l

0.66

1402

11601

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

3128

0.17

47.87

1.3

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2269

16765

1.43

47.75

1.3

15.84

12.73

u/ml

0.44

917

6400

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

10367

96819

1.44

46.17

4.5

4.0

1.31

1.29

mmol/l

1.35

10014

87968

(3036603) Volume of Urine

201

669

3.04

46.06

1.6

1901.81

1880.10

0.13

191

647

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

580

3084

1.92

46.00

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2312

17244

1.42

45.96

3.8

3.3

0.81

0.82

mmol/l

3.00

2195

16112

(3031040) Bacteria [#/volume] in Urine by Automated count

7717

68876

1.32

45.88

5.8

4.6

3050.15

1934.33

e6/l

0.32

988

(3017181) Myelocytes/100 leukocytes in Blood

1316

8805

1.55

45.11

4.2

4.1

0.71

0.98

3.21

345

3135

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

518

2682

1.97

44.42

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1894

13698

1.45

44.39

6.8

5.8

1.06

1.04

mmol/l

2.63

1806

12694

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

434

2110

2.10

44.29

1.2

32.84

44.32

u/ml

0.64

224

(3021960) Folate [Moles/volume] in Serum or Plasma

3124

24663

1.36

43.67

1.7

1.5

20.15

20.44

nmol/l

0.57

2968

20921

(3000494) Fungus identified in Specimen by Culture

1712

12181

1.47

43.62

1.7

1.4

—

(3036489) Thrombin time

656

3690

1.82

43.60

2.2

21.83

21.49

0.77

612

3221

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4024

33035

1.32

43.00

2.8

2.6

56.83

62.67

u/l

1.51

3890

30409

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

416

2015

2.10

42.87

2.0

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

448

2234

2.04

42.70

1.6

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8732

79637

1.33

42.64

4.2

4.1

14.27

14.85

pmol/l

88.96

8476

72138

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

524

2770

1.93

42.27

2.9

2.6

191.05

194.45

0.39

491

2633

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

156

485

3.24

40.16

3.1

3.5

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3299

26526

1.33

40.13

2.5

2.3

2.77

2.99

mg/l

5.59

2955

22629

(3025941) Bacteria identified in Stool by Culture

906

5706

1.63

39.93

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

10117

94642

1.38

39.69

7.7

5.8

40.88

39.86

mmol/mol

21.24

9884

87051

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

320

1449

2.24

39.11

1.1

135.54

7408.05

iu/ml

0.57

338

(3003694) ABO and Rh group [Type] in Blood

3354

27182

1.32

38.23

1.3

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1276

8812

1.50

37.35

2.4

2.5

66.33

g/l

0.01

1216

7922

(3023420) DNA double strand Ab [Units/volume] in Serum

252

1050

2.43

37.33

1.7

1.5

30.43

28.80

iu/ml

0.06

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2226

17036

1.37

36.98

2.0

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10668

101006

1.41

36.23

4.9

4.5

4.59

4.68

mmol/l

13.86

10356

93127

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10597

100231

1.40

36.10

4.8

4.4

1.44

1.48

mmol/l

21.35

10329

91872

(40761511) CBC panel - Blood by Automated count

11140

106353

1.48

35.86

16.9

13.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

300

1373

2.21

35.75

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

203

4.36

34.92

1.3

—

(3045414) Leukocytes [Presence] in Urine

755

4697

1.65

34.84

2.7

1.8

—

(3012501) Base excess in Blood by calculation

2490

0.21

34.79

2.7

4.1

2.62

2.57

mmol/l

0.04

1704

(3004716) Salmonella sp identified in Stool by Organism specific culture

770

4825

1.64

34.52

1.4

—

(3025159) Blasts/100 leukocytes in Blood

1154

7931

1.50

34.45

4.1

4.2

0.59

0.39

0.17

194

2290

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

193

736

2.65

34.44

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

193

736

2.65

34.44

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

192

732

2.65

34.28

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

193

738

2.64

34.25

1.2

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1628

11960

1.42

34.24

4.4

4.2

245.53

244.05

u/l

0.11

1568

11242

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

192

733

2.64

34.19

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

192

733

2.64

34.19

1.2

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

767

4822

1.63

33.93

1.7

1.55

1.56

g/l

0.01

701

4098

(3038177) Helicobacter pylori Ab [Presence] in Serum

329

1599

2.09

33.65

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

929

6127

1.56

33.55

1.4

1.3

172.39

224.06

u/ml

1.74

873

5621

(3048689) Calprotectin [Mass/mass] in Stool

1648

12190

1.41

33.26

2.4

2.2

130.07

134.93

ug/g

0.24

1444

9540

(3024891) Influenza virus A+B Ag [Presence] in Specimen

462

2539

1.85

33.06

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

529

3031

1.78

32.99

2.4

93.26

91.52

0.96

507

2914

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

369

1888

1.98

32.76

1.3

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3868

32465

1.28

32.63

3.9

3.8

8.87

9.26

mg/mmol

0.23

2965

19991

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

10516

99677

1.37

32.42

4.9

4.6

6.11

5.94

mmol/l

26.30

10162

90484

(3047007) Chlamydophila sp Ab [Presence] in Serum

286

1342

2.16

32.06

1.3

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10814

103064

1.39

31.41

5.3

5.0

2.72

2.75

mmol/l

3.85

10499

94547

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

216

4.05

31.38

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

3327

27522

1.29

31.20

2.8

2.6

12236.48

4203.67

umol/l

10.29

3067

23871

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

144

503

2.88

30.43

1.2

—

(3010421) pH of Blood

2873

0.31

29.86

2.6

4.0

7.41

7.42

1.19

2611

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

519

3047

1.73

29.73

1.3

1.6

0.16

10.07

iu/ml

1.12

183

667

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

6870

62010

1.24

29.72

3.0

2.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

596

3643

1.67

29.41

2.4

2.3

513.01

592.87

ug/l

0.21

571

3411

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

494

2878

1.75

29.08

2.8

2.7

3.56

3.60

g/l

0.23

469

2734

(3009445) Proteinase 3 Ab [Units/volume] in Serum

706

4533

1.59

28.56

1.4

1.5

10.57

15.30

u/ml

0.36

118

(3003327) Ova and parasites identified in Stool by Light microscopy

552

3338

1.68

28.37

1.6

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

929

6352

1.50

28.25

1.3

73.37

52.39

au/ml

1.19

351

(3021788) Differential panel - Synovial fluid

358

1912

1.90

28.04

1.6

1.5

—

(40761535) Cells panel - Urine sediment

562

8919

0.61

27.85

3.1

3.5

—

(3044889) 12 lead EKG panel

7914

72814

1.24

27.61

3.5

3.8

—

(3002619) Bacteria identified in Specimen by Culture

197

3.98

27.53

1.6

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

211

3.86

27.39

1.9

2.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1580

11963

1.37

27.29

2.4

2.5

1.74

1.79

1.11

1471

10540

(3003888) Timothy IgE Ab [Units/volume] in Serum

297

1503

2.00

27.26

1.1

2.39

5.06

u/ml

4.44

137

756

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2714

22192

1.29

27.22

1.3

1.75

1.77

u/ml

0.03

529

5923

(3008401) Mugwort IgE Ab [Units/volume] in Serum

287

1441

2.02

26.93

1.1

0.44

1.06

u/ml

2.13

112

612

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

287

1442

2.01

26.88

1.2

2.96

3.64

u/ml

0.34

478

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

390

2172

1.82

26.77

1.2

4.08

4.04

u/ml

0.01

169

(3026389) Candida sp identified in Specimen by Organism specific culture

295

1512

1.97

26.12

1.5

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

163

660

2.49

25.82

1.2

88.80

86.55

u/l

0.08

136

567

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1204

8808

1.41

25.50

3.2

3.8

1.24

1.23

mmol/l

11.02

1162

7642

(3003396) Base excess in Arterial blood by calculation

1575

12050

1.35

25.30

7.6

7.1

1.05

1.11

mmol/l

0.22

1270

9595

(3012494) Peanut IgE Ab [Units/volume] in Serum

233

3.58

25.22

1.0

1.1

0.68

5.31

u/ml

0.69

126

(3013139) Helicobacter pylori Ag [Presence] in Stool

977

6914

1.45

24.86

1.3

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

275

1404

1.98

24.65

1.2

2.78

4.35

u/ml

2.97

117

613

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

157

641

2.47

24.46

1.2

26.49

22.73

u/l

0.28

132

534

(3051387) C reactive protein [Mass/volume] in Capillary blood

391

2242

1.77

24.36

3.7

3.6

25.24

27.59

mg/l

0.75

317

1390

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1572

12091

1.34

24.32

7.6

7.1

5.17

5.08

kpa

2.52

1494

11536

(3042631) Mycobacterium sp identified in Specimen

1504

0.15

24.26

2.2

2.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1571

12087

1.34

24.25

7.6

7.1

12.45

12.34

kpa

0.35

1493

11526

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1273

9492

1.38

24.00

2.2

370.94

374.95

nmol/l

0.30

1205

8684

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

428

2548

1.70

23.34

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

145

3306

0.43

23.21

3.1

4.3

4.02

3.88

mmol/l

2.59

132

3280

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

437

2624

1.69

23.09

1.3

21.28

4.31

u/ml

0.57

283

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

441

2658

1.68

22.98

1.3

16.72

6.29

u/ml

1.03

439

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

556

3561

1.59

22.72

1.3

1.6

67.50

293.60

titre

—

161

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

467

2885

1.64

22.13

1.3

74.91

38.03

u/ml

0.81

186

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

578

3766

1.56

21.92

1.9

1.6

—

(3000492) Spirometry study

1278

9699

1.35

21.44

1.6

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

123

478

2.59

21.31

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

123

478

2.59

21.31

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

152

653

2.34

21.23

1.6

1.7

—

(4146454) Self-monitoring of blood glucose

1161

0.10

21.11

2.4

2.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

196

3857

0.50

20.84

3.0

4.1

1.57

1.39

mmol/l

1.02

171

3803

(36660697) Celiac disease serology panel - Serum

1067

7911

1.38

20.72

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

552

3625

1.55

20.22

2.7

3.2

0.28

0.35

u/ml

7.42

301

2092

(3023410) Appearance of Cerebral spinal fluid

195

950

2.07

19.99

1.7

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

137

4.03

19.88

1.9

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

256

1379

1.87

19.64

6.2

6.5

11.74

11.77

mg/l

0.04

242

1261

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

475

3054

1.58

19.12

1.9

1.6

0.24

g/l

0.20

448

2883

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

105

400

2.64

18.99

2.7

2.6

—

(3036180) Methadone [Presence] in Urine

345

2.77

18.85

2.9

2.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

292

1663

1.77

18.71

1.2

1.1

1.19

2.10

u/ml

0.98

126

830

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

2310

0.39

18.70

2.2

3.3

84.35

586.85

u/ml

3.03

2104

(3007916) DNA double strand Ab [Titer] in Serum

131

3.98

18.53

1.4

1.3

58.00

271.32

titre

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

125

524

2.40

18.51

2.2

2.5

1124.80

1143.31

u/ml

0.02

125

516

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

353

2130

1.68

18.38

1.4

16.50

28.95

e6/l

0.76

283

1642

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

353

2131

1.68

18.35

1.7

1.5

894.99

1224.62

e6/l

0.35

289

1737

(3045424) Erythrocytes [Presence] in Urine

1818

0.33

17.99

1.8

1.5

—

(1002224) Polysomnography panel

562

3813

1.50

17.69

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

270

2.94

17.56

2.4

2.0

16.13

39.76

u/l

1.63

247

(3008757) Leukocyte morphology finding [Identifier] in Blood

1203

0.20

17.42

3.7

4.0

—

(3024263) Appearance of Synovial fluid

122

522

2.35

17.29

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

196

1013

1.95

17.10

1.1

94.81

95.51

0.14

183

948

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

476

3154

1.53

16.78

1.9

1.6

1.18

1.19

g/l

0.30

451

2979

(3017732) Neutrophils [#/volume] in Blood

505

7363

0.67

16.63

2.4

3.0

4.48

4.96

e9/l

0.41

476

5809

(3005719) IgG [Mass/volume] in Serum or Plasma

1015

7723

1.34

16.60

3.1

2.7

10.27

10.48

g/l

0.78

965

7069

(3035947) Staphylolysin Ab [Units/volume] in Serum

113

480

2.37

16.30

1.2

1.1

3.25

3.40

iu/ml

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2346

19843

1.23

16.28

3.2

3.1

2.46

mmol/l

0.22

2024

17341

(3021879) Hepatitis B virus core Ab [Presence] in Serum

907

6806

1.36

16.25

1.5

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

131

599

2.20

15.91

1.3

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

113

488

2.33

15.72

1.1

0.36

1.75

u/ml

1.21

159

(40768797) Stomach Pathology biopsy report

1779

14680

1.25

15.48

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

291

1748

1.68

15.48

1.7

1.5

113.91

115.91

u/ml

0.11

380

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

173

3213

0.53

15.37

1.6

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

223

1246

1.80

15.32

2.8

2.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

166

845

1.98

15.19

2.4

2.1

1.94

1.93

u/field

0.01

354

(3000034) Microalbumin [Mass/volume] in Urine

1008

0.19

15.07

2.6

3.0

165.90

53.80

mg/l

0.43

737

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

328

2050

1.62

14.94

7.3

5.4

5381.47

1374.40

iu/ml

0.40

295

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

116

520

2.24

14.82

1.2

1.3

6.13

5.88

mmol/l

0.83

110

490

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1795

0.39

14.76

1.4

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

287

2.69

14.64

1.7

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

423

2821

1.52

14.51

1.5

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

131

622

2.12

14.51

1.8

1.5

5.10

6.26

u/l

1.85

110

520

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

872

6623

1.34

14.41

1.2

174.95

146.41

iu/ml

0.86

241

2493

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

505

0.10

14.38

2.0

2.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

142

3.46

14.35

5.8

5.5

—

(44813793) Dust mix specific IgE antibody measurement

138

672

2.07

14.31

1.2

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

803

6045

1.35

14.08

1.9

1.34

1.35

g/l

0.02

757

5493

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1084

8533

1.30

13.86

4.3

2.6

64.96

64.71

ml/min/173m2

0.06

341

3460

(3001729) Color of Synovial fluid

4.23

13.58

1.1

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

142

717

1.99

13.36

1.8

1.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

155

817

1.91

12.88

1.1

1.2

132.50

191.04

titre

0.48

144

(3051651) Icteric interference index of Serum or Plasma

126

620

2.04

12.76

3.2

3.5

—

(3016502) Oxygen saturation in Arterial blood

1325

10822

1.25

12.49

8.5

7.5

95.00

95.65

2.94

1276

10409

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

302

1943

1.57

12.26

1.7

1.4

20.29

17.29

u/ml

0.18

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

174

969

1.81

12.19

2.2

2.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

303

1954

1.56

12.17

1.7

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

255

1579

1.63

12.15

3.8

2.7

484.11

1983.49

u/ml

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

448

3139

1.44

12.05

1.4

275.53

274.83

ug/g

0.03

299

1816

(3035637) Corticotropin [Mass/volume] in Plasma

217

1292

1.69

12.04

1.7

1.5

—

(21494755) Public health laboratory ask at order entry panel

638

8441

0.74

11.78

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1772

15011

1.21

11.74

1.8

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

558

4111

1.37

11.26

1.3

1.2

0.47

1.07

u/ml

1.33

395

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

736

5664

1.32

11.12

10.9

9.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

259

1650

1.58

11.02

1.4

1.6

0.77

g/l

0.01

235

1231

(21494815) CD4 cells/100 lymphocytes in Specimen

151

834

1.82

10.92

2.1

2.3

39.06

0.00

151

816

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

396

2770

1.44

10.79

1.8

2.0

11.68

11.30

mg/l

0.33

381

2566

(3026470) Cobalt [Mass/volume] in Blood

126

661

1.92

10.71

2.1

2.0

5.17

3.56

ug/l

0.68

120

599

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

472

3415

1.40

10.64

2.8

3.3

45.97

47.18

mg/l

0.06

453

2748

(40760888) Immunoglobulin light chains.free panel - Serum

372

2579

1.46

10.63

2.5

3.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

173

1003

1.74

10.63

1.6

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

472

3418

1.40

10.59

2.8

3.3

58.88

71.46

mg/l

0.30

450

2747

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

229

1433

1.61

10.52

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

259

0.00

10.52

0.0

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

187

1114

1.69

10.42

3.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

273

1784

1.54

10.41

2.9

3.5

2.25

1.56

1.36

223

1592

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

102

503

2.04

10.36

2.3

2.1

53.58

154.50

ug/min

1.09

118

(3029075) Extractable nuclear Ab panel - Serum

286

2.39

10.21

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

133

3.09

10.13

1.1

1.4

42.17

54.91

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

489

2.03

10.03

1.0

2.10

1.24

u/ml

0.26

126

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

267

1752

1.54

10.01

1.2

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

142

793

1.80

9.95

1.9

1.5

—

(3034426) Prothrombin time (PT)

335

2.25

9.82

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

217

1364

1.60

9.82

1.2

1.1

123.19

117.31

1.66

197

1225

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

105

534

1.97

9.81

1.9

2.3

98.85

96.65

0.24

496

(3026250) Tacrolimus [Mass/volume] in Blood

427

2.09

9.75

39.3

34.9

7.36

7.27

ug/l

0.10

390

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

763

0.26

9.58

1.9

1.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

125

682

1.84

9.47

1.3

1.4

12.51

12.60

umol/l

0.06

116

644

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

454

0.20

9.43

3.1

2.0

—

(40768793) Breast Pathology biopsy report

147

2481

0.59

9.42

1.2

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

108

564

1.92

9.37

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

349

2453

1.44

9.32

1.3

1.4

579.59

525.30

mg/l

0.44

339

2327

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

450

0.20

9.28

3.1

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

450

0.20

9.28

3.1

2.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

746

0.27

9.23

1.9

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

450

2.03

9.23

27.4

27.0

104.32

114.05

ug/l

0.64

373

(3014271) Vancomycin [Susceptibility]

580

0.17

9.22

3.5

3.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

325

2.22

9.22

1.8

2.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

163

2.77

9.18

1.0

0.70

2.52

u/ml

0.54

133

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

4.41

9.06

1.1

11.34

22.70

u/ml

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

225

3403

0.65

8.99

1.3

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4246

39141

1.13

8.97

5.4

4.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

345

2441

1.43

8.91

2.0

2.2

131.91

128.27

g/l

1.90

269

1742

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

986

0.37

8.86

1.6

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

310

2153

1.45

8.85

1.3

3.99

3.77

mmol/l

2.20

294

2022

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

645

5034

1.30

8.83

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

268

1811

1.49

8.80

1.4

1.3

267.58

280.38

u/ml

0.29

188

1125

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

558

0.18

8.75

2.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

558

0.18

8.75

2.5

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

449

3336

1.36

8.67

2.8

3.2

1.48

2.59

ratio

0.97

261

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

203

1297

1.57

8.63

1.2

1.3

7.36

7.50

mmol/l

0.29

154

1139

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

565

4350

1.31

8.57

1.8

1.9

39.33

39.21

u/l

0.05

496

3825

(3009466) Valproate [Moles/volume] in Serum or Plasma

215

1399

1.55

8.45

5.5

4.8

358.70

364.76

umol/l

0.26

193

1190

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3288

29920

1.13

8.43

5.2

5.0

4.61

3.27

ug/l

0.40

3102

26787

(3016650) Hepatitis A virus Ab [Presence] in Serum

239

1592

1.51

8.43

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

129

738

1.76

8.41

2.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

340

2.12

8.29

1.8

2.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

120

676

1.78

8.25

1.3

1.6

76.06

82.29

umol/l

1.78

120

676

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

401

2.03

8.24

2.5

2.0

55.36

65.02

ug/l

0.78

389

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

897

10882

0.81

8.21

3.1

3.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

862

0.36

8.18

1.2

1.5

—

(3012565) Volume of 24 hour Urine

548

0.20

8.17

1.4

2.2

1717.91

1921.05

0.30

481

(3023183) Ammonium ion [Moles/volume] in Plasma

305

2151

1.43

8.06

2.3

2.7

33.69

33.86

umol/l

0.04

278

1938

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

804

6526

1.25

7.99

2.9

3.3

4.38

4.44

pmol/l

0.92

740

5759

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

133

781

1.71

7.93

1.2

1.3

9.54

8.75

mmol/l

1.19

127

749

(3044290) Cell count panel - Cerebral spinal fluid

284

1983

1.44

7.93

1.5

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

4.42

7.88

1.1

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1153

0.46

7.79

4.3

3.8

58.95

47.20

u/ml

0.25

1137

(3048929) Epstein Barr virus Ab [Presence] in Serum

379

2795

1.37

7.72

1.4

1.2

—

(3003181) Sodium [Moles/volume] in Urine

274

1914

1.44

7.65

1.6

1.4

60.27

63.17

mmol/l

0.63

241

1521

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

827

6771

1.24

7.61

3.8

3.6

5.24

5.16

kpa

1.84

814

6388

(4200892) Spirometry reversibility

616

7709

0.79

7.47

1.5

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

417

1.95

7.42

3.7

4.9

2888.85

546.47

mg/l

0.38

302

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

201

1329

1.52

7.40

1.1

5.37

3.36

u/ml

0.53

593

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.53

7.40

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

375

2783

1.36

7.36

2.2

2.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

333

2.05

7.18

1.1

1.2

0.32

0.31

g/l

1.02

266

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

662

8177

0.80

7.17

1.7

—

(3025577) Chromium [Mass/volume] in Blood

112

646

1.74

7.17

2.1

2.0

2.33

2.45

ug/l

0.12

102

544

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

200

1331

1.51

7.16

1.3

327.66

326.32

pmol/l

0.02

181

1131

(3011985) Renin [Units/volume] in Plasma

210

1417

1.49

7.04

1.4

50.94

56.36

mu/l

0.18

195

1261

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

107

615

1.75

6.95

1.1

2.22

8.81

nmol/l

1.44

124

(3009343) pH of Capillary blood

809

6683

1.23

6.86

3.8

3.6

7.40

7.42

1.35

866

(40757373) Influenza virus identified in Isolate

202

2.33

6.85

1.9

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

148

2.57

6.83

9.5

11.6

6.29

5.35

mmol/l

0.63

148

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.44

6.82

1.5

1.6

2.41

1.83

mg/l

0.14

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.44

6.82

1.5

1.6

1.34

1.69

mg/l

0.18

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.44

6.82

1.5

1.6

0.44

1.50

mg/l

1.04

(3020393) Adenovirus Ag [Presence] in Stool

114

2.81

6.82

1.6

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

430

1.89

6.82

2.0

1.8

145.91

153.64

0.43

401

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

355

0.22

6.72

1.0

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1227

10559

1.18

6.70

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

433

1.88

6.68

1.2

1.1

240.22

171.38

iu/ml

0.49

427

(1175426) CD3 cells/100 lymphocytes in Blood

130

798

1.64

6.63

2.1

73.04

72.07

0.29

117

767

(3012516) Albumin [Mass/volume] in Urine

3358

30962

1.12

6.60

3.3

3.2

320.89

433.12

mg/l

0.90

2452

19290

(3004588) Protein electrophoresis panel - Serum or Plasma

881

7371

1.21

6.58

2.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

779

6442

1.22

6.55

3.7

3.6

2.96

1.80

mmol/l

13.49

546

4787

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

188

2.35

6.52

1.3

1.2

97.36

73.35

0.84

(3008898) HLA-B27 [Presence]

412

3162

1.31

6.48

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

609

0.33

6.47

1.3

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

129

2.64

6.45

2.7

1.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

229

1601

1.44

6.44

1.2

—

(3018572) Chloride [Moles/volume] in Blood

158

2387

0.66

6.40

6.5

6.9

104.54

105.09

mmol/l

0.58

142

2143

(3039000) Anion gap in Blood

158

2386

0.66

6.39

6.5

6.9

12.06

11.22

mmol/l

1.83

142

2142

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1305

11340

1.17

6.32

1.9

1.7

1.52

1.46

1.75

1193

9856

(3025130) Human papilloma virus identified in Specimen

182

1224

1.49

6.25

1.6

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

612

0.34

6.23

1.3

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

371

2823

1.32

6.22

2.2

2.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

360

2728

1.33

6.21

1.6

310.03

301.03

mu/l

0.20

333

2472

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

524

1.76

6.21

1.6

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1217

0.53

6.20

3.9

2.9

13.16

13.21

0.16

1199

(3008152) Bicarbonate [Moles/volume] in Arterial blood

541

6721

0.80

6.20

4.7

7.1

25.04

24.61

mmol/l

1.44

498

6403

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2511

27523

0.89

6.19

1.7

1.6

1.35

1.37

mmol/l

0.81

2401

22919

(3027008) Opiates [Presence] in Urine

373

2843

1.32

6.18

2.2

1.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

292

2.03

6.12

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

189

2.28

6.00

1.7

1.2

102.50

76.84

—

(3000285) Sodium [Moles/volume] in Blood

147

2.45

5.92

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

265

1933

1.38

5.88

1.4

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

166

2.35

5.86

1.1

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.29

5.84

1.2

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1413

0.58

5.69

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1412

0.59

5.67

1.5

1.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

109

2.66

5.64

3.3

2.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

195

2.21

5.60

1.1

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

227

1629

1.40

5.58

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1416

0.59

5.55

1.5

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

366

2829

1.30

5.53

1.2

81.36

142.80

titre

1.41

257

(3028300) Cannabinoids [Presence] in Urine

368

2849

1.30

5.50

2.2

2.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

159

2.33

5.47

1.8

1.4

10.00

9.28

0.05

(3022689) Creatine [Moles/volume] in Urine

311

0.26

5.46

1.5

—

(40768800) Prostate Pathology biopsy report

126

1909

0.66

5.26

1.2

—

(3016879) Cocaine [Presence] in Urine

339

2613

1.31

5.25

2.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

138

2.40

5.19

1.5

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

207

1482

1.40

5.19

1.2

1.1

22.13

11.82

au/ml

0.73

(3020961) Endomysium IgA Ab [Titer] in Serum

564

4628

1.23

5.18

1.1

96.50

186.05

titre

1.04

114

(3006462) Nitrate [Presence] in Urine

513

0.35

5.17

2.1

3.5

—

(3016228) CD19 cells/100 cells in Blood

419

1.77

5.17

1.8

2.0

7.50

8.59

0.40

412

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

134

885

1.52

5.11

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

192

1362

1.42

5.08

1.1

0.69

1.57

u/ml

2.62

122

667

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1063

9254

1.16

5.04

2.1

2.4

7.72

7.06

ug/l

0.30

987

7952

(3009871) Measles virus Ab [Titer] in Serum

321

1.87

5.04

1.5

1.7

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.17

5.03

1.6

1.3

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2.76

5.02

1.3

1.2

23.00

14.42

nmol/l

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

781

6632

1.19

5.02

11.5

8.8

0.56

0.68

14.31

768

6588

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

108

683

1.59

5.00

1.4

1.3

1.90

1.57

u/ml

0.09

379

(3011288) Drugs identified in Urine by Screen method

252

1879

1.35

4.94

2.9

2.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

274

1.94

4.94

1.9

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

154

1058

1.46

4.86

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

2.92

4.86

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

283

1.91

4.84

1.1

1.2

95.95

86.58

0.49

140

(3051593) INR in Capillary blood by Coagulation assay

523

0.38

4.80

18.7

11.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

105

668

1.58

4.76

1.2

1.5

—

(3016038) Potassium [Moles/volume] in Urine

110

708

1.56

4.74

1.8

1.2

33.64

35.23

mmol/l

0.32

600

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

189

1356

1.40

4.72

1.1

1.47

1.53

g/l

1.16

169

1225

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

121

0.00

4.71

0.0

2.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

212

2.03

4.60

1.5

1.7

169.94

110.15

au/ml

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1430

12799

1.13

4.55

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

174

1241

1.41

4.52

2.8

3.3

4.70

11.25

nmol/l

0.84

167

1211

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

291

1.86

4.48

1.1

89.32

86.93

0.14

138

(3015377) Calcium [Moles/volume] in Serum or Plasma

3827

36074

1.09

4.43

3.7

3.4

2.35

2.36

mmol/l

0.68

3563

31453

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.38

4.42

3.6

3.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

775

6657

1.18

4.39

11.3

8.7

1.18

1.38

4.78

762

6616

(3001019) Free T4 and TSH panel - Serum or Plasma

384

4754

0.80

4.36

1.6

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1425

0.64

4.34

1.5

1.4

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.20

4.33

1.2

1.1

0.06

0.07

g/l

0.43

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1127

9968

1.14

4.31

9.2

7.9

119.19

120.82

g/l

2.00

1098

9696

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.25

4.31

3.6

3.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

150

1053

1.43

4.28

1.5

1.4

6.51

6.69

g/l

0.23

139

722

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

132

2.28

4.27

1.2

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

137

948

1.45

4.23

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

1306

0.63

4.22

1.2

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

109

0.00

4.17

0.0

2.0

—

(3019060) Gas panel - Arterial blood

599

7066

0.84

4.16

3.6

4.8

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

149

1053

1.42

4.11

1.5

1.4

0.41

g/l

0.06

138

722

(3028192) IgG subclass 2 [Mass/volume] in Serum

149

1054

1.42

4.09

1.5

1.4

2.74

2.89

g/l

0.55

137

725

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

614

1.55

4.08

1.1

6.70

9.95

iu/ml

1.02

138

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

179

2424

0.73

4.08

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.08

4.07

1.4

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

281

2192

1.29

4.07

2.3

2.1

—

(4062490) Immunoglobulin typing, IgG

149

1058

1.41

4.02

1.5

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

498

4149

1.21

4.01

1.4

1.3

33.25

31.88

iu/l

0.41

446

3546

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1055

0.60

3.99

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

332

0.30

3.98

1.4

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

332

0.30

3.98

1.4

2.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

475

0.42

3.91

1.0

1.1

—

18.93

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

551

1.56

3.86

1.6

—

(3011412) CD3 cells [#/volume] in Blood

141

1001

1.41

3.83

2.3

2.4

1.18

1.17

e9/l

0.04

117

903

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.00

3.81

5.0

6.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

222

1695

1.32

3.80

1.9

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

569

1.55

3.80

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

448

5377

0.83

3.80

1.4

—

(3013637) Mi-2 Ab [Presence] in Serum

274

0.33

3.79

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

274

0.33

3.79

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

274

0.33

3.79

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

274

0.33

3.79

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1446

0.68

3.71

1.5

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

184

1374

1.34

3.68

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

174

1289

1.35

3.67

1.5

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

162

1193

1.36

3.56

1.2

63.54

63.17

u/l

0.02

142

1059

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

118

823

1.44

3.56

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

859

0.59

3.52

1.1

1.0

—

(3002179) Metamyelocytes/100 leukocytes in Blood

916

8107

1.14

3.51

3.9

4.0

0.44

0.71

4.76

245

2720

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

407

1.62

3.51

1.1

132.18

625.55

ng/l

1.33

(3020911) Cortisol [Moles/time] in 24 hour Urine

361

1.67

3.50

1.5

1.3

256.28

200.09

nmol/24h

0.12

361

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

286

1.75

3.50

1.4

1.2

46.46

423.41

ug/l

1.78

152

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4649

48540

0.93

3.49

7.3

6.0

1.21

mmol/l

1.45

4532

44086

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

274

3427

0.79

3.48

1.5

1.7

3.98

4.00

mg/l

0.01

204

2530

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

186

1406

1.33

3.46

2.2

2.6

1050.35

1168.03

u/ml

0.04

186

1389

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

185

2427

0.76

3.45

1.9

1.6

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

100

2.30

3.42

2.2

1.6

56.09

45.12

umol/l

0.62

100

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

100

682

1.47

3.40

1.2

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

113

2.21

3.40

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

333

0.36

3.39

1.0

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

850

0.60

3.39

1.2

72.83

38.31

u/ml

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

4.08

3.39

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

314

2545

1.24

3.37

2.1

4568.01

4824.52

u/l

0.06

110

958

(40768443) Skin Pathology biopsy report

556

4759

1.18

3.37

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

275

1.75

3.36

2.8

2.4

252.00

629.59

e6/l

0.71

148

(21494814) CD8 cells/100 lymphocytes in Specimen

412

1.61

3.35

1.9

2.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.83

3.35

2.5

2.4

—

(3019977) pH of Arterial blood

618

0.53

3.35

2.7

2.8

7.37

7.43

—

224

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

101

2.28

3.35

1.2

1.87

1.67

umol/24h

0.35

101

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1414

0.69

3.34

1.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.32

3.32

1.4

1.2

78.00

121.08

ug/l

0.92

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

313

2542

1.24

3.31

1.6

1.8

4.99

8.05

iu/l

0.42

920

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.62

3.29

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

533

1.52

3.29

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

561

0.52

3.27

1.1

1.3

217.45

323.40

u/l

1.50

514

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

1146

0.66

3.26

1.6

1.7

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

285

1.72

3.26

1.7

1.4

16.91

21.54

0.59

257

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

196

1507

1.31

3.25

1.3

0.15

0.25

nmol/l

—

108

(3050794) Legionella sp Ab [Presence] in Serum

2.34

3.23

1.0

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

338

2775

1.22

3.23

4.4

3.7

1.56

1.55

mg/l

0.06

293

2548

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

677

1.45

3.15

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

179

1.90

3.13

1.6

2.1

17.86

16.43

umol/l

0.33

179

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

112

795

1.41

3.12

1.3

1.6

20.14

24.05

u/ml

0.45

170

(3042733) HLA Ab [Presence] in Serum

320

1.66

3.10

4.8

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

557

1.49

3.10

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.67

3.08

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

925

0.64

3.07

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

925

0.64

3.07

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

925

0.64

3.07

1.6

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

194

1504

1.29

3.05

1.3

4.92

2.36

nmol/l

0.25

185

1447

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

413

0.46

3.04

2.2

2.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.50

3.03

1.2

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

149

1115

1.34

3.02

1.9

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

149

1115

1.34

3.02

1.9

1.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

122

885

1.38

3.01

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1384

0.71

3.00

1.4

1.3

35.98

30.34

u/l

0.82

1127

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

553

1.49

3.00

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

441

1.54

2.98

1.1

1.0

0.25

1.08

u/ml

0.69

120

(3042111) Morphology [Interpretation] in Bone marrow Narrative

222

1758

1.27

2.97

1.6

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

265

1.70

2.90

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

142

1.97

2.89

1.4

7.47

320346.87

nmol/l

1.08

118

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1114

0.68

2.88

1.4

1.7

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.71

2.87

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.50

2.86

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

303

3657

0.82

2.82

1.6

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

557

0.56

2.80

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

103

2.14

2.79

1.1

1.0

—

(40765096) Chromosome analysis panel by Banding

302

0.40

2.79

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

378

1.56

2.76

2.0

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

111

2.07

2.72

12.1

1.4

8.09

7.41

mmol/l

0.46

(3017354) Segmented neutrophils/100 leukocytes in Blood

144

1092

1.32

2.71

2.5

3.4

51.44

57.12

1.97

934

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

140

1836

0.76

2.69

1.9

1.7

—

(3011648) Oxygen content in Venous blood

113

827

1.37

2.68

2.5

2.7

11.41

10.90

0.61

113

827

(3024932) HLA-DR beta [Type]

304

1.61

2.63

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

257

3128

0.82

2.63

1.3

1.7

—

(40768795) Lymph node Pathology biopsy report

1069

0.69

2.62

1.3

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

162

1255

1.29

2.62

1.1

—

(3048879) Bone marrow aspiration report

306

0.42

2.60

1.2

1.8

—

(3036782) Glucose [Moles/volume] in Pleural fluid

127

952

1.34

2.60

1.6

1.3

6.63

6.36

mmol/l

0.48

118

871

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

319

0.44

2.58

1.4

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2172

20410

1.08

2.58

1.5

1.8

719.21

1187.77

nmol/l

243.15

1844

15263

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

988

10864

0.90

2.53

1.7

1.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

677

1.39

2.49

1.2

1.3

72.00

66.55

titre

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

438

1.49

2.45

2.5

1.9

143.93

139.00

umol/l

0.04

225

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

747

8324

0.89

2.45

1.9

2.0

—

(3014891) Appearance of Pleural fluid

144

1.88

2.45

1.3

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.09

2.42

1.3

1.1

—

(3024471) HLA-A [Type]

312

1.57

2.39

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

529

0.58

2.37

3.1

3.9

—

(3037756) Immunofixation for Serum or Plasma

272

2264

1.21

2.37

1.4

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

458

1.47

2.37

1.1

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.12

2.36

1.4

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

475

1.46

2.35

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

161

1267

1.27

2.34

1.5

1.4

2762.32

2573.74

e6/l

0.07

117

905

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

399

0.53

2.34

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

264

0.42

2.34

1.0

1.1

—

(3010503) CD19 cells [#/volume] in Blood

626

1.39

2.33

2.0

2.5

0.12

0.41

e9/l

1.51

609

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

208

2549

0.81

2.32

1.4

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

318

0.47

2.32

3.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

299

1.57

2.31

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

217

1773

1.23

2.29

1.4

1.3

—

(3045788) Cell count panel - Pleural fluid

127

974

1.31

2.26

1.4

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

156

0.32

2.26

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

148

1159

1.28

2.26

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

943

0.70

2.26

1.4

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

422

1.47

2.25

2.0

2.3

51.31

52.93

umol/l

0.17

355

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

125

958

1.31

2.24

1.7

1.5

39.69

29.74

1.97

573

(3017569) Oxygen content in Arterial blood

515

1.42

2.21

2.6

2.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

359

1.51

2.20

3.1

2.8

32.79

28.15

umol/l

1.93

266

(3003434) Protein [Mass/volume] in Pleural fluid

177

1423

1.25

2.18

1.7

1.4

32.19

32.49

g/l

0.11

160

1272

(3052592) Norovirus Ag [Presence] in Stool

211

0.43

2.18

2.0

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2580

24537

1.07

2.16

3.2

3.8

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

3.69

2.15

2.4

2.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

145

1141

1.27

2.14

1.4

1.5

51132.24

61419.24

e6/l

0.23

100

659

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

330

1.52

2.12

1.4

1.9

7535.94

15615.97

e6/l

0.58

176

(3040151) Glucose [Moles/volume] in Capillary blood

1208

0.74

2.12

12.7

11.8

8.43

7.36

mmol/l

1.95

1007

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

130

1.85

2.11

4.2

2.6

1.38

1.37

mmol/l

0.01

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

742

1.34

2.10

1.2

37.83

40.40

mg/l

0.31

624

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.00

2.10

2.7

2.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

323

1.52

2.10

1.8

1.4

1.40

2.63

0.80

270

(3023520) Reticulocytes [#/volume] in Blood

988

9068

1.10

2.09

2.2

2.6

69.84

69.74

e9/l

0.03

717

6887

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

691

0.66

2.07

1.1

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

175

0.40

2.02

4.7

7.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

749

1.32

1.99

1.9

1.4

13.92

12.53

u/l

0.87

717

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

148

0.34

1.99

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

684

0.67

1.99

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

272

0.48

1.98

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

179

1461

1.23

1.96

1.5

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

682

1.34

1.95

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

202

1.64

1.94

2.3

2.0

—

(3044007) Cell count panel - Peritoneal fluid

297

1.52

1.94

1.6

1.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

228

1909

1.20

1.93

1.6

1.9

4.76

5.03

mmol/24h

0.58

212

1668

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

235

1.58

1.89

1.1

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

201

1668

1.21

1.88

1.9

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

201

1668

1.21

1.88

1.9

1.6

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

1.87

0.0

1.0

—

8.34

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.16

1.87

1.1

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

292

1.51

1.86

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.86

1.86

1.0

1.1

0.24

0.21

g/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

100

1.90

1.85

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

376

1.44

1.81

1.6

2.1

2515.40

4356.35

e6/l

0.25

253

(3027456) Digoxin [Moles/volume] in Serum or Plasma

181

2184

0.83

1.81

3.2

3.1

0.83

nmol/l

0.09

154

1653

(1616796) Gas panel - Central venous blood

278

2384

1.17

1.81

2.2

3.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

631

1.33

1.80

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

710

1.31

1.79

2.3

2.6

672.15

676.99

e6/l

0.03

687

(3035880) pH of Pleural fluid

555

1.35

1.78

1.5

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.17

1.77

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

107

1363

0.78

1.77

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

109

1.84

1.76

1.1

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

107

1362

0.78

1.76

1.4

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.33

1.74

2.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

107

1360

0.78

1.74

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

107

1358

0.79

1.72

1.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.67

1.72

1.0

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

389

1.42

1.71

1.7

1.4

67.34

64.75

0.26

317

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

629

1.32

1.70

1.1

—

(40758358) Immune stain study

0.00

1.69

0.0

1.0

—

(3012898) Urea [Moles/volume] in Urine

104

1.83

1.66

1.3

145.21

157.18

mmol/l

0.17

(3002079) Sodium [Moles/time] in 24 hour Urine

459

1.37

1.66

1.1

1.2

134.83

159.51

mmol/24h

1.65

459

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.50

1.66

1.0

1.1

6.11

6.91

u/ml

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

2.50

1.66

1.3

1.1

1.64

1.83

mg/l

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.25

1.63

4.5

4.1

12.35

9.28

—

(3044242) Glucose [Moles/volume] in Arterial blood

546

0.68

1.60

3.4

2.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

263

0.53

1.59

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

102

804

1.27

1.58

1.1

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

223

1.53

1.56

1.1

0.78

0.65

umol/24h

0.71

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.27

1.55

1.3

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

1.52

0.0

1.0

—

(3002256) Pathology report gross observation

1458

13782

1.07

1.51

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

124

1.69

1.46

1.3

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

140

1.64

1.44

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.92

1.43

1.1

1.0

—

(3028433) Virus identified in Specimen by Culture

376

0.64

1.41

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

122

997

1.23

1.41

1.4

123275.77

149263.59

e6/l

0.14

671

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

435

0.67

1.40

1.0

1.1

1304.47

1502.82

miu/ml

0.65

435

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

322

1.40

1.37

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

120

0.42

1.37

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.61

1.36

1.5

3.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

768

1.25

1.36

1.1

303.45

288.68

mg/l

1.25

691

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

112

1.70

1.35

1.1

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

1.34

0.0

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.14

1.33

1.0

0.70

0.39

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

114

1386

0.82

1.32

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

114

1386

0.82

1.32

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

402

1.34

1.31

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

258

1.44

1.30

1.1

1.2

292.90

289.82

pmol/l

0.02

185

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

1.84

1.29

1.1

1.2

1.22

1.12

ml/s/173m2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

617

5687

1.09

1.29

2.7

3.6

65.30

64.88

u/ml

0.01

599

5477

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

694

7485

0.92

1.29

1.9

—

(3042517) Benzodiazepines panel - Urine

1.88

1.28

1.5

2.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

173

2020

0.85

1.28

2.1

3.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

570

1.28

1.27

2.3

2.7

46.70

39.43

1.14

341

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

370

1.35

1.26

1.8

1.5

—

1243465.79

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

353

0.65

1.26

1.4

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

338

1.36

1.22

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

132

1569

0.84

1.22

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.04

1.21

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

399

1.33

1.21

1.8

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

264

2338

1.13

1.20

1.3

1.4

11.50

11.16

u/l

0.14

232

1875

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

210

1832

1.15

1.19

1.6

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

138

1167

1.18

1.17

1.7

1.6

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.77

1.16

1.2

1.1

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

1.16

0.0

1.3

—

1.36

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

1.16

0.0

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

152

0.53

1.13

1.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

2.33

1.12

1.0

—

(3049717) Cytology report of Urine Cyto stain

433

3960

1.10

1.11

2.3

2.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

115

0.43

1.11

1.0

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

119

1.60

1.11

1.5

1.4

73.14

74.65

0.08

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.96

1.11

1.1

0.86

0.25

u/ml

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.38

1.09

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

104

1.64

1.09

1.1

1.2

—

(40768804) Tissue Pathology biopsy report

4386

42892

1.03

1.08

2.2

2.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

169

1.48

1.06

1.4

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

470

1.28

1.06

3.7

5.0

41.56

9186.74

u/ml

—

(3020491) Glucose [Moles/volume] in Blood

740

1.22

1.05

1.2

2.0

6.66

6.88

mmol/l

0.31

517

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

276

2476

1.12

1.05

1.5

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.71

1.05

2.2

2.8

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.27

1.03

1.4

1.6

180.40

257.06

nmol/l

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1061

10068

1.06

1.03

2.3

2.2

0.22

0.21

g/l

4.98

971

9374

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.92

1.02

1.3

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

111

937

1.19

1.00

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

105

1245

0.84

0.99

1.4

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4111

40211

1.03

0.99

4.0

3.7

50.48

73.41

ng/l

0.88

2985

27942

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

511

1.25

0.99

1.1

1.05

1.08

u/l

0.20

241

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.17

0.98

1.0

1.1

2.40

2.78

—

(40758292) HTLV I+II Ab panel - Serum

159

0.57

0.98

1.8

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

424

0.73

0.97

1.0

1.1

108.27

94.29

1.39

335

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

272

0.66

0.97

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

283

0.67

0.95

1.2

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.95

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

149

1.48

0.95

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

282

0.67

0.94

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

880

8336

1.06

0.93

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

121

1039

1.17

0.91

1.0

1.1

—

8.45

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

313

1.31

0.91

1.1

1.2

48.40

24.68

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

225

2507

0.90

0.91

1.8

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

270

1.33

0.90

1.4

1.3

147.33

129.78

nmol/l

0.23

197

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.75

0.90

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

135

1173

1.15

0.88

1.1

2.76

3.56

u/ml

0.26

543

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

369

1.27

0.86

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

685

6459

1.06

0.86

2.5

2.1

11.14

12.48

nmol/l

3.75

618

5721

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

616

0.79

0.86

1.3

168.46

180.17

pmol/l

0.23

616

(3036670) Protein [Mass/volume] in Synovial fluid

334

1.29

0.85

1.1

1.2

35.30

39.74

g/l

1.13

172

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

526

0.78

0.85

15.4

12.2

853.83

840.74

nmol/l

0.07

503

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

604

1.21

0.85

1.2

1.3

1.53

1.57

g/l

0.40

604

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

239

0.67

0.84

1.4

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

680

1.19

0.82

1.0

774.45

714.22

ng/l

0.58

452

(3026692) Albumin [Mass/volume] in Peritoneal fluid

267

1.31

0.80

1.3

1.5

16.42

13.42

g/l

1.39

206

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

113

978

1.16

0.80

2.3

2.4

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.79

0.0

1.4

—

36.81

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

683

1.19

0.79

1.0

30.94

44.28

ng/l

5.17

458

(3019150) Specific gravity of Urine by Refractometry

2304

22415

1.03

0.77

3.8

4.3

1.01

1.02

kg/l

18.13

1206

3131

(3017817) Protein [Mass] in Urine collected for unspecified duration

955

0.85

0.77

1.6

2.4

—

0.14

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

150

1690

0.89

0.77

1.8

1.9

186.58

198.16

pmol/l

0.84

134

1592

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

112

974

1.15

0.75

4.9

4.8

31.64

85.83

u/ml

3.18

286

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.64

0.75

1.2

1.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

678

1.18

0.75

1.0

325.51

327.83

ng/l

0.01

463

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

124

1.45

0.74

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

855

1.16

0.74

1.3

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

107

0.56

0.72

1.3

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1546

15976

0.96

0.72

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

356

0.76

0.72

1.3

1.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

130

1469

0.88

0.71

1.4

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

416

1.23

0.71

1.1

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.92

0.70

3.8

9.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

203

1.33

0.70

5.0

5.5

114.96

59.00

u/l

0.42

197

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.71

0.69

1.1

232.00

282.59

nmol/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.71

0.69

1.7

8.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.55

0.69

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

118

1337

0.88

0.68

1.7

1.5

52.11

58.05

0.84

836

(3034891) Synovial lining cells/100 cells in Synovial fluid

510

1.20

0.68

1.9

1.5

3.64

4.06

0.08

114

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

128

1441

0.89

0.67

1.7

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

104

911

1.14

0.66

2.3

2.0

17.03

7.48

umol/l

1.24

657

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

283

0.74

0.66

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2338

23948

0.97

0.65

3.7

4.4

22.60

21.92

1.24

1179

11879

(3000093) Morphology [Interpretation] in Blood Narrative

114

1006

1.13

0.65

1.1

—

(3012441) Differential panel - Pleural fluid

125

1111

1.13

0.64

1.4

1.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

189

1.32

0.64

1.3

1.2

1.98

1.62

mmol/l

0.57

111

(3038071) Oxygen [Partial pressure] in Mixed venous blood

224

0.71

0.63

3.8

7.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2234

22884

0.97

0.63

1.8

1.7

398.92

32934538.73

pmol/l

16.67

2032

18786

(3008295) Osmolality of Serum or Plasma

1103

0.88

0.62

1.6

1.4

275.14

278.39

mosm/kgh2o

0.50

844

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

176

0.68

0.61

2.1

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

438

4130

1.06

0.61

2.2

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

164

0.67

0.61

3.0

2.8

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

577

0.83

0.61

1.1

1.2

1.02

1.06

ratio

—

202

(3045683) HLA typing for celiac disease panel - Blood or Tissue

572

1.17

0.61

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

113

1.42

0.61

1.2

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.60

0.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

175

0.69

0.60

1.2

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.60

0.0

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

154

1699

0.91

0.59

1.3

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

341

3638

0.94

0.59

2.2

2.7

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.58

0.0

1.0

—

12181.25

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

114

0.61

0.57

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

253

0.75

0.57

4.0

7.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.54

0.55

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

282

2634

1.07

0.54

1.3

255.36

218.59

miu/ml

0.68

1178

(3023419) Bacteria identified in Sputum by Culture

175

1603

1.09

0.54

3.0

2.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

116

1.38

0.54

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

103

1153

0.89

0.53

1.4

1.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.48

0.53

1.0

1.5

282.78

325.07

umol/24h

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

116

1042

1.11

0.53

1.1

—

(3004451) EKG impression Narrative

525

1.16

0.53

1.3

—

(3011048) Pyruvate [Moles/volume] in Blood

1.52

0.52

1.3

100.00

85.20

umol/l

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

791

0.87

0.52

1.1

1.3

2.13

2.09

mmol/l

0.10

745

(3042951) Complement C1q Ab [Units/volume] in Serum

1.50

0.51

1.0

1.1

—

20.08

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

1.41

0.51

1.2

1.3

—

10925.00

—

(3037121) Protein [Mass/volume] in Urine

345

3655

0.94

0.51

2.6

3.1

0.25

0.32

g/l

1.01

198

1505

(3047352) Trisomy 18 risk [Likelihood] in Fetus

100

1116

0.90

0.50

1.4

—

(3022475) Manganese [Moles/volume] in Blood

1.49

0.49

1.0

1.3

—

(4035726) Immunohistochemistry procedure

928

9593

0.96

0.49

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1050

0.89

0.49

2.5

3.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

471

4490

1.05

0.49

2.2

2.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.52

0.48

1.6

—

0.08

—

(3005033) Fetal Nuchal fold Thickness US

100

1111

0.90

0.47

1.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.49

0.47

12.9

8.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

710

1.13

0.47

2.5

2.6

410.54

507.46

e6/l

1.67

601

(3036048) Francisella tularensis Ab [Titer] in Serum

233

0.77

0.47

1.1

1.2

—

421.82

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

147

1600

0.92

0.46

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

477

1.15

0.45

2.0

1.6

4.11

4.90

nmol/l

0.14

396

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

0.67

0.45

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.40

0.45

1.3

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

112

1.34

0.44

1.4

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

449

0.85

0.44

1.2

1.4

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.40

0.44

3.3

2.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

275

0.80

0.44

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

140

0.71

0.43

1.0

1.2

—

87.31

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.65

0.42

1.0

2.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.43

0.41

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.41

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.41

0.0

2.4

—

(3034614) HLA Ag [Interpretation]

0.00

0.40

0.0

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.36

0.40

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

681

6587

1.04

0.39

1.5

1.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

105

0.67

0.39

1.0

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.5

—

105.56

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.39

0.0

2.7

—

2.04

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

5.6

—

0.18

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

107

980

1.09

0.38

1.1

1.0

0.11

0.37

u/ml

1.13

281

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

915

0.91

0.37

1.2

1.3

1.12

1.48

nmol/l

3.18

821

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

112

0.71

0.37

1.1

1.7

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.63

0.35

1.0

1.1

5.60

13.16

u/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

461

1.13

0.34

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

155

0.77

0.33

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

155

0.77

0.33

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

155

0.77

0.33

1.1

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

127

1183

1.07

0.32

2.0

2.5

1.32

1.27

g/24h

0.08

576

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

587

1.11

0.32

1.2

1.1

—

(3044927) Protein electrophoresis panel - Urine

101

1093

0.92

0.32

1.1

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

220

0.82

0.32

1.0

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1745

17167

1.02

0.31

2.9

3.1

0.70

0.78

ug/l

2.44

1351

11602

(3002331) Protein [Mass/volume] in Peritoneal fluid

231

1.17

0.29

1.3

1.4

235.83

26.73

g/l

0.50

179

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.25

0.29

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

106

0.75

0.29

3.7

2.3

—

(21494434) Karyotype in Bone marrow

892

1.08

0.28

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.27

0.27

1.3

1.2

—

(3047181) Lactate [Moles/volume] in Blood

322

3343

0.96

0.27

4.5

6.0

1.46

1.30

mmol/l

1.75

304

2958

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

183

0.82

0.27

1.3

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

121

0.74

0.27

1.0

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

778

1.08

0.27

1.3

1.4

1.65

1.28

promille

1.74

594

(21494890) Protein electrophoresis panel - 24 hour Urine

104

1112

0.93

0.26

1.8

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

111

1040

1.07

0.26

1.2

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

1.19

0.26

1.3

38.25

1509.15

u/l

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.26

0.26

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.69

0.26

1.2

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

170

1.18

0.24

2.6

2.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

137

0.80

0.24

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

381

0.89

0.24

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

505

0.91

0.23

1.5

1.7

—

(3017509) Phencyclidine [Presence] in Urine

1.25

0.22

1.2

1.6

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

221

0.86

0.22

2.0

3.0

48.59

133.86

ng/l

—

100

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

564

1.08

0.22

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.21

0.0

1.5

—

(40768806) Pleura Pathology biopsy report

119

1129

1.05

0.21

1.6

1.5

—

(4212803) Bone marrow aspirate examination

1.22

0.21

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.16

0.21

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1605.38

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

472

4606

1.03

0.21

1.7

1.9

—

(3035933) Granulocytes/100 leukocytes in Blood

272

0.88

0.20

1.3

1.6

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.20

0.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.2

—

1.61

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

121

1268

0.95

0.18

1.4

0.24

0.35

nmol/l

2.66

943

(3051339) Copper [Moles/volume] in Blood

1.17

0.17

1.3

1.1

14.92

16.94

umol/l

—

(3009508) Creatinine [Moles/volume] in Urine

3254

32763

0.99

0.17

3.3

3.2

7.24

7.35

mmol/l

0.72

3030

27365

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.15

0.17

1.0

1.1

—

4.11

—

(3033799) Differential panel - Peritoneal fluid

339

1.09

0.17

1.5

1.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

141

1354

1.04

0.17

1.2

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

111

1060

1.05

0.17

1.4

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

349

1.09

0.17

1.2

1.7

—

(3045142) Bone marrow Pathology biopsy report

120

1150

1.04

0.16

1.4

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

782

0.95

0.16

1.2

1.4

2.17

3.93

ug/l

3.20

642

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.78

0.15

3.0

4.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

487

1.07

0.15

1.2

1.3

37.60

62.83

—

(3000012) Reticulocyte production index

149

1544

0.96

0.15

1.6

2.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

326

3188

1.02

0.14

1.6

1.7

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.19

0.14

2.2

1.5

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

122

1.15

0.13

9.6

10.5

0.34

umol/l

0.04

114

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

242

0.91

0.13

1.0

1.1

—

(3022145) Colonoscopy Study observation

1184

11733

1.01

0.12

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

113

1094

1.03

0.11

1.0

1.1

4.39

4.19

u/ml

0.03

436

(3050129) First trimester maternal screen panel - Serum or Plasma

164

1682

0.97

0.10

1.3

1.4

—

(40768441) Liver Pathology biopsy report

781

1.04

0.10

1.2

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.09

0.09

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate

449

1.05

0.08

1.3

1.2

—

(3017704) Immunofixation for Urine

583

0.96

0.08

1.2

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

765

1.03

0.08

2.8

2.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

328

0.94

0.08

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

195

0.92

0.08

1.8

1.6

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.06

0.08

1.1

1.2

—

2.06

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.83

0.07

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

176

1.08

0.07

1.2

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

120

1173

1.02

0.07

1.0

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.87

0.06

1.1

1.0

—

14.57

iu/ml

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

739

1.03

0.06

1.5

1.3

14.10

12.78

u/l

0.23

674

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

234

0.94

0.06

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

456

0.96

0.05

1.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

316

1.04

0.05

1.3

47.64

56.10

0.56

265

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

138

1403

0.98

0.05

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

277

1.05

0.05

1.1

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

323

0.96

0.05

2.6

2.5

1.06

1.14

ug/l

0.16

303

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

0.93

0.03

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

229

2306

0.99

0.02

2.1

2.5

16.43

16.10

0.81

204

1167

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

269

2706

0.99

0.02

1.1

5.61

7.86

u/ml

0.43

311

(3022313) Gas panel - Capillary blood

488

4861

1.00

0.02

3.9

3.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

680

0.99

0.02

6.6

6.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

760

0.99

0.02

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

559

0.98

0.02

1.7

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

559

0.98

0.02

1.7

1.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

193

1.04

0.01

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

213

1.03

0.01

1.2

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

265

2658

1.00

0.01

1.3

—

(4281824) Cell count and differential, peritoneal fluid

125

1243

1.01

0.00

1.1

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

217

1.01

0.00

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

237

1.01

0.00

1.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

134

0.97

0.00

5.8

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

134

0.97

0.00

2.9

3.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

145

0.97

0.00

1.4

1.2

0.68

1.64

mmol/l

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

169

1686

1.00

0.00

1.6

1.2

85.69

38.16

u/l

1.19

160

1460

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

289

1.00

0.00

1.6

8.37

8.89

ug/l

0.41

289

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.98

0.00

1.7

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.0

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

690

1.00

-0.00

2.6

0.25

0.23

e9/l

0.25

597

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

530

1.00

-0.00

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.97

-0.00

1.7

3.6

—

0.00

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.89

-0.00

15.4

4.5

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

37.17

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

-0.00

0.0

1.4

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.49

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.4

—

10.71

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.92

-0.00

8.8

9.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.89

-0.00

1.0

2.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: Z21_SPEECH_THERAPY – Speech therapy

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Speech therapy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Speech therapy (Z21_SPEECH_THERAPY)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints